{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "cwd = os.getcwd()\n",
    "cwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Collecting pdfminer\n",
      "  Downloading pdfminer-20191125.tar.gz (4.2 MB)\n",
      "Requirement already satisfied: pycryptodome in c:\\users\\ja903976\\anaconda3\\lib\\site-packages (from pdfminer) (3.10.1)\n",
      "Building wheels for collected packages: pdfminer\n",
      "  Building wheel for pdfminer (setup.py): started\n",
      "  Building wheel for pdfminer (setup.py): finished with status 'done'\n",
      "  Created wheel for pdfminer: filename=pdfminer-20191125-py3-none-any.whl size=6140142 sha256=0618df62d4e05c55aebef1bb07622a2559990a21e77aed7de532831ae7d5a548\n",
      "  Stored in directory: c:\\users\\ja903976\\appdata\\local\\pip\\cache\\wheels\\1c\\28\\7d\\f390b82bb0307deb63ff27a1474fd308ec68ee028cb9ab6283\n",
      "Successfully built pdfminer\n",
      "Installing collected packages: pdfminer\n",
      "Successfully installed pdfminer-20191125\n",
      "Note: you may need to restart the kernel to use updated packages.\n"
     ]
    }
   ],
   "source": [
    "pip install pdfminer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "import sys\n",
    "from pdfminer.pdfinterp import PDFResourceManager, PDFPageInterpreter\n",
    "from pdfminer.pdfpage import PDFPage\n",
    "from pdfminer.converter import XMLConverter, HTMLConverter, TextConverter\n",
    "from pdfminer.layout import LAParams\n",
    "import io\n",
    "\n",
    "def pdfparser(data):\n",
    "\n",
    "    fp = open(data, 'rb')\n",
    "    rsrcmgr = PDFResourceManager()\n",
    "    retstr = io.StringIO()\n",
    "    laparams = LAParams()\n",
    "    device = TextConverter(rsrcmgr, retstr, \n",
    "                           laparams=laparams)\n",
    "    \n",
    "    # Create a PDF interpreter object.\n",
    "    interpreter = PDFPageInterpreter(rsrcmgr, device)\n",
    "    # Process each page contained in the document.\n",
    "\n",
    "    for page in PDFPage.get_pages(fp):\n",
    "        interpreter.process_page(page)\n",
    "        data =  retstr.getvalue()\n",
    "\n",
    "    return(data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "mypdf = 'C:/Users/ja903976/OneDrive - BioMarin/Desktop/Studies/BMRN270/270-301/ExternalLab/Covance_ControlledDocs/BioMarin_270-301_Covance_DTS_Final V17.0_01Dec2020_signed.pdf'\n",
    "\n",
    "output = pdfparser(mypdf)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "\" \\n\\nData Transfer Specifications \\n\\n \\n \\n\\n \\n\\n \\n\\n \\n \\n\\nData Transfer Specifications  \\n\\n \\n\\nSafety Laboratory Data Plus Specialty Laboratory Data \\n\\nProtocol:  270-301 \\n\\nProtocol Description:   \\nA Phase 3 Open-Label, Single-Arm Study to Evaluate the Efficacy and \\nSafety of BMN 270, an Adeno-Associated Virus Vector–Mediated Gene \\nTransfer of Human Factor VIII in Hemophilia A Patients with Residual \\nFVIII Levels ≤ 1 IU/dL Receiving Prophylactic FVIII Infusions  \\n \\n\\nVendor:  \\n \\nData Type: \\n \\n\\nAuthor: \\n \\nVersion Date: \\n \\nDocument Version: \\n \\n\\n \\n\\n \\n\\n \\n\\nCovance \\n\\nSafety data (Chemistry, Hematology, \\nCoagulation, Urinalysis). \\nSpecialty data (Factor VIII Activity, Factor VIII \\nInhibitors, AA, Blood, saliva, semen, urine, stool \\nvector shedding, Biomarkers, HCV RNA storage, \\nHBV DNA storage, AAV5, HIV, HLA).  \\nJason Delosh  \\n11Dec2020 \\n\\n17.0 \\n\\n\\x0c \\n\\n  Overview .................................................................................................................................... 3 \\n\\n  Data Transfer Information .......................................................................................................... 4 \\n\\n  Table and Field Specifications ..................................................................................................... 8 \\n\\n \\n\\n Summary of Changes ............................................................................................................... 10 \\n\\nAPPENDIX 1 – Visit Names ................................................................................................................ 11 \\n\\nAPPENDIX 2 – Laboratory Test Identifiers, Short and Long Names .................................................... 18 \\n\\nAPPENDIX 3 – Laboratory Names ...................................................................................................... 31 \\n\\nAPPENDIX 4 – Planned Timepoints ................................................................................................... 31 \\n\\nAPPENDIX 5 – Signature Page...…………………………………………………………………………………….…………………32 \\n\\n \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 2 of 43 \\n\\n\\x0c  Overview \\n\\nThis document describes  the  requirements for  the  transfer of  Safety laboratory data plus specialty \\nLaboratory data.  Covance will be responsible for analysis and generation of results for the following \\ncategories: Chemistry, Hematology, Urinalysis, Coagulation (see Appendix 2 for details of all tests). \\n \\nCovance will transfer data file, the MS Excel with the FVIII Genotyping lab results separately.  \\n \\nIn addition, Covance will be responsible for receiving all samples and results from individual \\nSpecialty labs and reporting them in the data transfer. Details of individual labs and samples \\nthat will be sent to Covance are as follows: \\n \\n\\nLAB NAME \\n\\nTEST NAME \\n\\nColorado Coag Lab  \\nCorp \\n\\nFVIII ACTIVITY ONE-STAGE  \\nFVIII ACTIVITY CHROMOGENIC \\nFVIII INHIBITOR LEVEL (EXP) \\nFVIII INHIBITOR LEVEL REPEAT \\nVON WILLERBRAND FACTOR ANTIGEN \\n\\nEurofins \\n\\nFVIII TOTAL ANTIBODY TITER \\nAAV5 TOTAL ANTIBODY POST-DOSE \\n\\nCovance Harrogate \\n\\nPrecision for \\nMedicine \\n\\nBLOOD VECTOR SHEDDING \\nSALIVA VECTOR SHEDDING \\nSEMEN VECTOR SHEDDING \\nSEMEN FRACTIONATION \\nURINE VECTOR SHEDDING \\nSTOOL VECTOR SHEDDING \\n\\nSM / EXPL PLASMA BIOMARKER \\nSM / EXPL CELLS BIOMARKER \\nSM / EXPL SERUM BIOMARKER \\nSM / EXPL RED BLOOD CELLS \\nSM / PBMC ALIQUOTS \\nSM / DNA EXTRACTION \\nSM / HCV RNA STORAGE \\nSM / HBV DNA STORAGE \\nSM / FVIII COAG EXPLORATORY \\n\\nCONTACT DETAILS \\n\\n8490 Upland Drive, Suite 100 \\n80112 Englewood \\nUSA \\nTel: +1 800 4449111 \\nFax: +1 720 5684313 \\nContact:  Paige Macy    \\nPhone +1720-568-4320   \\nEmail:  macyp@labcorp.com \\n\\n90 Park Drive, Milton Park \\nOX14 4RY Abingdon \\nUnited Kingdom \\nTel: +44 1235 444141 \\nContact: Joanne Heredge          \\nEmail: joanneheredge@eurofins.com \\nManaging Director: Antonio Marques  \\nEmail: AntonioMarques@eurofins.com \\n\\nOtley Road, HG3 1PY Harrogate                 \\nNorth Yorkshire \\nUnited Kingdom \\nTel: +44 142 3500011 \\nFax: +44 142 3569595 \\nContact:  Amanda Hawkins   \\nPhone:  +441323635695              \\nEmail:  amanda.hawkins@covance.com \\n\\nLong Term Storage: \\n8425 Precision Way, Suite M \\nFrederick, MD 21701             \\nContact: Ruth Chin     \\nEmail: \\nBioMarin.mailbox@precisionformedicine.com \\n \\nPBMC: \\n2686 Middlefield Road, Suite D  \\nRedwood City, CA 94063 \\nSr. PM, Project Management: Namrata Panday \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 3 of 43 \\n\\n\\x0cLAB NAME \\n\\nTEST NAME \\n\\nCONTACT DETAILS \\n\\nARUP \\n\\nAAV5 TOTAL ANTIBODY PRE-SCREEN \\nABO Typing \\n\\nGenosafe \\n\\nCELL-BASED AAV5 TI \\n\\nEmail: \\nNamrata.Panday@precisionformedicine.com \\n\\n500 Chipeta Way \\n84108-1221 Salt Lake City \\nUSA \\nTel: +1 801 583 2787 \\nFax: +1 801 583 2712   \\nContact:  Toni Pollock/Cynthia Levinthal   \\nPhone:  +18015832787 ext. 3387                                     \\nEmail:  cynthia.levinthal@aruplab.com \\n\\n1 rue de l’internationale \\n91002 Evry \\nFrance \\nTel: +33 169 471157 \\nFax: +33 169 471161   \\nContact Sabrina Triffault   \\nPhone:  +33169472994   \\nEmail:  striffault@genosafe.com \\n\\nLabCorp Burlington \\n\\nHIV-1 QUALITATIVE, RNA \\n\\nSingapore General \\nHospital \\n\\nHIV AB CONFIRMATION \\n\\nEsoterix \\n\\nTHROMBIN GENERATION ASSAY \\n\\n \\n\\n \\n\\n \\n\\nBloodworks Northwest  \\n921 Terry Avenue \\n98104 Seatle \\nUSA \\nTel: +1 206 6896594 \\nContact:  Gayle Teramura    \\nphone:  +12066896542  \\n Email:  gaylet@bloodworksnw.org \\n\\nBloodworks  \\nNorthwest \\n\\nHLATYPING \\nFVIII GENOTYPING \\n\\n \\n\\n  Data Transfer Information \\n\\n \\n\\nFile Format: SAS dataset \\n\\nWinZip file name: 270301_covance_lb_ddmmmyy.zip \\n\\na)  Header file  \\n\\nSAS dataset name for header file: bmn_270301_covance_header_ddmmyy.sas7bdat \\n \\n\\nb)  A separate password-protected file containing FVIII activity (One Stage & Chromogenic) + \\n\\nFVIII protein only. \\nSAS dataset name for FVIII activity results file: \\nbmn_270301_covance_lb_blinded_ fviii_ddmmmyy.sas7bdat \\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 4 of 43 \\n\\n\\x0cc)  a non-password-protected file containing all other test results \\n\\nSAS dataset name for results file: bmn_270301_covance_lb_ddmmmyy.sas7bdat \\n\\n \\n\\n \\n\\nd)  Bloodworks FVIII Genotyping results file in csv: \\n\\nbmn_270301_bloodworks_genotyping_ddmmmyy.csv \\n\\n \\n\\n  Method of Transfer and Security \\n\\nData will be transmitted via Covance sftp .   \\n\\nData transfer notification emails should be sent to BMT-EDT@bmrn.com, \\nAnn.Mikhail@bmrn.com, Sherri.Bloomer@bmrn.com, charlotte.furey@bmrn.com and \\nadrian.hsing@bmrn.com \\n\\nData described in section 2.1 a, b, and c will be transmitted daily. Data described in section 2.1 \\nd will be transmitted on an ad-hoc basis. \\n\\n \\n\\nType of Transfer \\n\\nAll transfers are to be cumulative data transfers only.  Definition of cumulative is to include all \\nnew, updated and previously transmitted data with each data transfer.  Deleted data records \\nwill not be included in the recent cumulative data transfers. \\n\\n \\n\\nTest Transfer \\n\\nA test transfer will be prepared by the external vendor and sent via sFTP to verify the \\nstructure and process of creating and transferring the data file.  The test transfer may include \\nreal data or mocked-up data, but must be in the structure defined by these specifications, and \\nall data must fall within the expected domain of values for each field. \\n\\nAny issues identified in the test transfer will be communicated to the laboratory and further test \\ntransfers will be sent until all issues are resolved. When the data structure has been accepted, \\ntransfer of live data can commence. \\n\\n \\n\\nTest Identification \\n\\nLab tests included are those identified in the 270-301 protocol.  Tests should be given the long \\nand short lab test names and lab test identifiers as specified in Appendix 2: Laboratory Test \\nIdentifiers, Short and Long Names. \\n\\n \\n\\nTransfer Frequency \\n\\nProduction data transfer to BioMarin should occur daily and should only be initiated once the \\ntest transfer has been approved.   More frequent transfers may be requested prior to key \\nevents, e.g., interim analyses or study closeout. \\n\\n  Reference Ranges and Alert Flags \\n\\nOnly when applicable, reference range limits will be included as separate variables in the \\ntransfer.  Results will be explicitly flagged as normal, low or high based on the standard result \\nin comparison with the standard reference range.   \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 5 of 43 \\n\\n\\x0cResults equal to the lower or upper reference limits are considered to be within the normal \\nlimits. Where applicable, character lab tests should be compared with the character reference \\nrange and flagged as either normal or abnormal.   \\n\\nAlert flags should be set to null if there are insufficient data to allow setting of the flags. \\n\\n  Result Reporting \\n\\nResults should be reported in two ways, with the corresponding low and high reference range \\nlimits converted as well as the results.   \\n\\n2.8.1 \\n\\nIn the original units, as stated on the original lab report (original reporting units) \\n\\n2.8.2 \\n\\nIn Standard SI units \\n\\n2.8.3 \\n\\nIn Standard conventional units.  These may be the same as the original reporting units \\nif all reports for a test are given in the same conventional units.   \\n\\nWhen results for a given test are intended to report whether the target of measurement is \\npresent or not, the term “negative” will be reported to reflect not present. \\n\\nWhen results for a given test are on a continuous scale, a zero will be used to represent a level \\nof zero. \\n\\n  Missing Data \\n\\nWhere scheduled samples are drawn but no results are available due to missing samples, \\ninsufficient quantity, damaged sample, etc., a record should be included in the transferred \\ndata for each expected but missing assay result.  The result should be null with the reason for \\nthe missing result provided in the “reason not done” field.  \\n\\n  Data Discrepancies \\n\\n  Data discrepancies may be identified and communicated to COVANCE by the Clinical Data \\n\\nManager (CDM) at BioMarin.  COVANCE will research and clarify the discrepancies as needed \\nand make any indicated data corrections following their established process for applying and \\ndocumenting corrections. Corrections will be made within 5-10 business days. Blinding \\n\\nThere is no applicable blinding in this study, as results will be programmatically masked. Please \\nrefer to the file structure outlined in Section 2.1 for further detail. \\n\\nBlinded FVIII tests are: \\n\\nLab Test Name (LBTEST)  Protocol/ Covance- \\n\\nCovance Test Code \\n\\nFactor VIII Activity One \\nStage  \\n\\nFactor VIII Activity \\nChromogenic \\n\\nSpecified Lab test \\n\\nFVIII AOSCNaCitpl(-70)LDT104QT \\n\\nORT17362 \\n\\nFVIIIAcChrNaCitpl(-70)LDT104QT \\n\\nORT17363 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 6 of 43 \\n\\n\\x0cLab Test Name (LBTEST)  Protocol/ Covance- \\n\\nCovance Test Code \\n\\nSpecified Lab test \\n\\nFVIII Activity OSC \\nExpedited \\n\\nFVIIIAOSCNaCitpl(-70)EXPLDT104 \\n\\n \\nFVIIIAOSC,SI(-70)EXPLDT104 \\n\\n \\n\\n \\n\\nFVIII Activity OSC \\nExpedited Backup \\n\\nFVIIIAOSCBU(-70)EXPLDT104 \\n\\n \\nFVIIIAOSC,SI BU(-70)EXPLDT104 \\n\\n \\n\\n \\n\\nFVIII Activity OSC \\nExpedited Comment \\n\\nFVIII Activity \\nChromogenic Expedited \\n\\nFVIII Activity \\nChromogenic Expedited \\nBackup \\n\\nFVIII Activity \\nChromogenic Expedited \\nComment \\n\\nB‐domain Deleted Factor \\nVIII \\n\\nB-deleted FVIII Out of \\nStability  \\n\\nB-domain Deleted Factor \\nVIII Reanalysis \\n\\n \\n\\n \\n\\n \\n\\n \\n \\n\\n \\n\\n \\n\\n \\n \\n\\n \\n\\n \\n\\n \\n\\nFVIIIAOSC,Commen(-70)EXPLDT104 \\n\\nFVIIIAcCh,SI(-70)EXPLDT104 \\n\\nFVIIIAcChNaCitpl(-70)EXPLDT104 \\n\\nFVIIIAcChBU(-70)EXPLDT104 \\n\\nFVIIIAcCh,SI BU(-70)EXPLDT104 \\n\\nFVIIIAcCh,Commen(-70)EXPLDT104 \\n\\nBDelF8Pri,NaCitpl(-70)LDT104PS \\n\\nFVIIIAntiNaCitpl(-70)LDT104PS \\n\\nORT19229 \\n(AMT37448), \\nORT19209 (AMT37447)  \\n\\nORT19208 \\n(AMT37446), \\nORT19210 (AMT37445) \\n\\nORT19211 \\n\\nORT19213 \\n(AMT37443),   \\nORT19230 (AMT37444) \\n\\nORT19212 \\n(AMT37442), \\nORT19214 (AMT37441) \\n\\nORT19215 \\n\\nORT19899 \\n\\nORT23961 \\n\\nORT23962 \\n(AMT37442), \\nORT23963 (AMT37441) \\n\\nORT23965 \\n(AMT37446), \\nORT23966 (AMT37445) \\n\\nBDelF8PrimNaCitpl(-70)LDT104PS \\n\\nORT19687 \\n\\nFactor VIII Activity \\nChromogenic ISR \\n\\nFVIIIACSCNaCitpl(-70)LDT104PS, \\nFVIIIACSSINaCitpl(-70)LDT104PS \\n\\nFactor VIII Activity One \\nStage ISR \\n\\nFVIIIAOSCNaCitpl(-70)LDT104PS, \\nFVIIIAOSSINaCitpl(-70)LDT104PS \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 7 of 43 \\n\\n\\x0c  Table and Field Specifications \\n\\n \\n\\nLab Field Specifications for Central Laboratory Data \\n\\nVar. \\n\\n# \\n\\nVariable Name \\n\\nVariable Label \\n\\nType \\n\\nLength  Description \\n\\n1. \\n\\n PROJECT \\n\\nStudy identifier \\n\\nChar \\n\\n6 \\n\\nStudy name. Value = 270301 \\n\\n2. \\n\\n SUBJECT \\n\\nSubject ID \\n\\nChar \\n\\n3. \\n\\n BRTHDTN \\n\\nDate of Birth \\n\\nNum \\n\\n9 \\n\\n8 \\n\\n4. \\n\\n FOLDERNAME \\n\\nVisit Name \\n\\nChar \\n\\n40 \\n\\n5. \\n\\n LBDAT \\n\\n6. \\n\\n LBTIM \\n\\nSample Collection \\nDate \\n\\nSample Collection \\nTime \\n\\nNum \\n\\nChar \\n\\n8 \\n\\n5 \\n\\n7. \\n\\n LBREFID \\n\\nSpecimen identifier \\n\\nChar \\n\\n14 \\n\\n8. \\n\\n LBTESTCD \\n\\nTest Short Name \\n\\nChar \\n\\n9. \\n\\n LBSPID \\n\\nLab Test Identifier \\n\\nChar \\n\\n8 \\n\\n4 \\n\\n10. \\n\\n LBTEST \\n\\nTest Name \\n\\nChar \\n\\n50 \\n\\n \\nLBTPT \\n \\n\\n11. \\n\\n12. \\n\\n LBCAT \\n\\n13. \\n\\n LBSCAT \\n\\n \\nPlanned Timepoint \\n\\n \\nChar \\n\\n \\n\\n40 \\n\\nCategory for Lab \\nTest \\n\\nChar \\n\\n25 \\n\\nSubcategory for Lab \\nTest \\n\\nChar \\n\\n34 \\n\\n14. \\n\\n LBORRES  \\n\\nResult or Finding in \\nOriginal Units \\n\\nChar \\n\\n40 \\n\\n9 character subject id (Site ID – \\nSubject Number (e.g., XXXX-XXXX). \\nExample:  0109-1001. \\nBirth date as a SAS date variable \\nwith the format date9, e.g., \\n01Jan2000.   \\nCharacter visit description.  \\nReference Appendix 1 for list of \\nvisits and visit numbers. \\nCollection date as a SAS date \\nvariable with the format date9, e.g., \\n01Jul2010.   \\n24-hour time with hour and \\nminutes separated by colon.  \\nExample: 15:30 \\n COVANCE accession number, \\nunique per collected sample. \\nShort name of lab test.  Reference \\nAppendix 2 for list of lab test short \\nnames. \\nUnique lab test identifier.  \\nReference Appendix 2 for list of \\nidentifiers. \\nLong name of laboratory test \\nperformed.   Reference Appendix 2 \\nfor a list of test names. \\nIf timepoints are needed, nominal \\ntime point for timed sample \\ncollection. Will be null if not a timed \\nsample. \\nLab Test Category, e.g., \\n‘Hematology’, ‘Chemistry’, \\n‘Urinalysis’, etc.  Reference \\nAppendix 2 for a list of categories. \\nFurther categorization of a test \\ncategory.  Reference Appendix 2 for \\na list of subcategories. \\nResult of the measurement or \\nfinding as originally captured in the \\noriginal units collected.  If null, then \\nreason must be specified for \\nLBREASND. \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 8 of 43 \\n\\n\\x0cOriginal units in which the data \\nwere collected.  Required if numeric \\nresult unless units are not \\napplicable (e.g., pH). \\n\\nLower end of Reference Range for \\nnumeric tests, in original units. \\n\\nUpper end of Reference Range for \\nnumeric tests, in original units. \\n\\nResult in standard format and/or \\nstandard conventional units.  \\nIncludes both numeric and \\ncharacter results. \\n\\nChar \\n\\nChar \\n\\n6 \\n\\n6 \\n\\nChar \\n\\n40 \\n\\n16. \\n\\n LBORNRLO \\n\\n17. \\n\\n LBORNRHI \\n\\n18. \\n\\n LBSTRESC \\n\\n19. \\n\\n LBSTRESN \\n\\nReference Range \\nLower Limit in \\nOriginal Unit \\nReference Range \\nUpper Limit in \\nOriginal Unit \\n\\nCharacter \\nResult/Finding in \\nStandard Format \\n\\nNumeric \\nResult/Finding in \\nStandard Units \\n\\nVar. \\n\\n# \\n\\nVariable Name \\n\\nVariable Label \\n\\nType \\n\\nLength  Description \\n\\n15. \\n\\n LBORRESU \\n\\nOriginal Units \\n\\nChar \\n\\n15 \\n\\nNum \\n\\n15 \\n\\nResult in standard conventional \\nunits for all numeric results. \\n\\n20. \\n\\n LBSTRESU \\n\\nStandard Units \\n\\nChar \\n\\n15 \\n\\n21. \\n\\n LBSTNRLO \\n\\n22. \\n\\n LBSTNRHI \\n\\n23. \\n\\n LBSTNRC \\n\\n24. \\n\\n LBSIRES  \\n\\nReference Range \\nLower Limit in \\nStandard Units \\nReference Range \\nUpper Limit in \\nStandard Units \\n\\nReference Range for \\nStandard Character \\nResults \\n\\nResult or Finding in \\nSI Units \\n\\n25. \\n\\n LBSIRESU \\n\\nSI Units \\n\\n26. \\n\\n LBSINRLO \\n\\n27. \\n\\n LBSINRHI \\n\\nReference Range \\nLower Limit in SI \\nUnits \\nReference Range \\nUpper Limit in SI \\nUnits \\n\\nChar \\n\\n6 \\n\\nChar \\n\\n10 \\n\\nChar \\n\\n25 \\n\\nChar \\n\\nChar \\n\\nChar \\n\\nChar \\n\\n40 \\n\\n15 \\n\\n6 \\n\\n6 \\n\\n28. \\n\\n LBNRIND \\n\\nReference Range \\nIndicator \\n\\nChar \\n\\n4 \\n\\nUnits for standard result, using \\nstandard conventional units. \\nLower end of Reference Range for \\nnumeric tests, in standard \\nconventional units. \\nUpper end of Reference Range for \\nnumeric tests, in standard \\nconventional units. \\nNormal range value(s) or range for \\nstandard character or non-\\ncontinuous results, e.g., ‘-1 to +1’ or \\n‘NEGATIVE’. \\nResult of the measurement or \\nfinding as originally received or \\ncollected.  \\nStandard International (SI) units for \\nLBSIRES.  \\n\\nLower end of Reference Range for \\nnumeric tests, in SI units. \\n\\nUpper end of Reference Range for \\nnumeric tests, in SI units. \\n\\nHigh/Low flag indicating whether \\nthe standard result falls within, \\nbelow or above reference range or \\nLBSTNRC.  Values are: ‘null’ = \\nNormal or not evaluable due to \\ninsufficient data \\n  ‘L’ = Low (below low range) \\n  ‘H’ = High (above upper range) \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 9 of 43 \\n\\n\\x0cVar. \\n\\n# \\n\\nVariable Name \\n\\nVariable Label \\n\\nType \\n\\nLength  Description \\n\\n29. \\n\\n LBNAM \\n\\n30. \\n\\n LBSTAT \\n\\nLaboratory Name \\n\\nTesting Status \\n\\nChar \\n\\nChar \\n\\n30 \\n\\n20  \\n\\n31. \\n\\n LBREASND \\n\\nReason Test Not \\nDone  \\n\\nChar \\n\\n160 \\n\\n32. \\n\\n LBSPEC \\n\\nSpecimen type \\n\\nChar \\n\\n20 \\n\\n33. \\n\\n COMMENTS \\n\\nComments \\n\\nChar \\n\\n1000 \\n\\n34. \\n\\nLBRESDAT \\n \\n\\nResult Enter Date \\n\\nNum \\n\\n \\n\\n35. \\n\\n LBRESTIM \\n\\nResult Enter Time \\n\\nChar \\n\\n8 \\n\\n5 \\n\\nName of the laboratory performing \\nthe test \\nStatus of the test e.g. Done, Not \\nDone \\nReason for missing result.  Value \\nexpected when LBORRES is null and \\nshould be null otherwise.  \\ne.g., ‘SERUM’, ‘BLOOD’ or ‘URINE’ \\nSee Lab Dataset Reference Guide \\nfor list. \\nAdditional information relevant to \\nthe interpretation or analysis of the \\ntest result. \\nEnter date as a SAS date variable \\nwith the format date9, e.g., \\n01Jul2010.   \\n\\n24-hour time with hour and \\nminutes separated by \\ncolon.  Example: 15:30 \\n\\n \\n\\n \\n\\nLBSAMP_MAPPING Field Specifications for Lab Sample Mapping File  \\n\\nVar. #  Variable Name \\n\\nVariable Label \\n\\nType \\n\\nLength  Description \\n\\n1. \\n\\n PROJECT \\n\\nStudy identifier \\n\\nChar \\n\\n6 \\n\\nStudy name. Value = 270301. \\n\\n2. \\n\\n SUBJECT \\n\\nSubject ID \\n\\nChar \\n\\n3. \\n\\n BRTHDTN \\n\\nDate of Birth \\n\\nNum \\n\\n9 \\n\\n8 \\n\\n4. \\n\\n FOLDERNAME \\n\\nVisit Name \\n\\nChar \\n\\n40 \\n\\n5. \\n\\n6. \\n\\n LBDAT \\n\\n LBTIM \\n\\nSample Collection \\nDate \\n\\nSample Collection \\nTime \\n\\nNum \\n\\nChar \\n\\n8 \\n\\n5 \\n\\n7. \\n\\n LBREFID \\n\\nSpecimen identifier \\n\\nChar \\n\\n14 \\n\\n8. \\n\\n SAMPDESC \\n\\nSample Description  \\n\\nChar \\n\\n80 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n9 character subject id (Site ID – \\nSubject Number (e.g., XXXX-XXXX). \\nExample:  0109-1001. \\n\\nDate as a SAS numeric date variable \\nwith the format date9, e.g., \\n01Jan2000.   \\nCharacter visit description.  See \\nAppendix 1 for list of visits and \\nmapping of FOLDERNAME. \\nCollection date as a SAS date \\nvariable with the format date9, e.g., \\n01Jul2010.   \\n24-hour time with hour and minutes \\nseparated by colon.  Example: 15:30 \\nAccession number, unique per \\ncollected sample and provided to \\nspecialty labs performing additional \\nsample assays. \\nDescription of Sample and \\ntube/aliquot. \\n\\nPage 10 of 43 \\n\\n\\x0cVar. #  Variable Name \\n\\nVariable Label \\n\\nType \\n\\nLength  Description \\n\\n9. \\n\\n LABVISIT \\n\\nLabeled Visit Name \\n\\nChar \\n\\n40 \\n\\n10. \\n\\n LBTPT \\n\\nPlanned Timepoint \\n\\nChar \\n\\n40 \\n\\nVisit name as described on the \\nsample label or otherwise within the \\nLabs database. LABVISIT will \\ngenerally match Foldername. \\nIf timepoints are needed, nominal \\ntime point for timed sample \\ncollection.  Will be null if not a timed \\nsample. \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 11 of 43 \\n\\n\\x0c \\n\\n Summary of Changes \\n\\nVersion \\n\\nDate \\n\\nAuthor  \\n\\n1.0 \\n\\n2.0 \\n\\n3.0 \\n\\n19JAN2018 \\n\\n07MAR2018 \\n\\n17MAY2018 \\n\\nGenevieve C. \\nDeMaria \\n\\nGenevieve C. \\nDeMaria \\n\\nGenevieve C. \\nDeMaria \\n\\nTitle \\n\\nCDM  \\n\\nCDM \\n\\nCDM \\n\\n4.0 \\n\\n21Jan2018 \\n\\nGenevieve C. \\nDeMaria \\n\\nCDM \\n\\n5.0 \\n\\n6.0 \\n\\n7.0 \\n\\n7Mar2019 \\n\\nInessa Levitt \\n\\nCLS CDM \\n\\n2Apr2019 \\n\\nInessa Levitt \\n\\nCLS CDM \\n\\n10May2019 \\n\\nInessa Levitt \\n\\nCLS CDM \\n\\n8.0 \\n\\n8Jul2019 \\n\\nInessa Levitt \\n\\nCLS CDM \\n\\n9.0 \\n\\n15NOV2019 \\n\\nCosmas Collins \\n\\nCDM \\n\\n10.0 \\n\\n06JAN2020 \\n\\nCosmas Collins \\n\\nCDM \\n\\nDescription of changes \\n\\nInitial Version \\n\\nAppendix 1 updated per protocol; \\nAppendix 2 updated per Covance \\nrequest \\nAdded Fasting Lipid Panel to Appendix \\n2; updated Appendix 2 \\nChange LBTEST and SAMPDESC variable \\nlength and delete/update duplicate test \\ncodes, per Covance’s request. Removed \\nPBMC from results file, move to header \\nfile only. Added highlighted test codes. \\nUpdated visit section, added \\nhighlighted visits. Changed blinding \\nsection. Added Appendix 2.1. Updated \\nsignature section.  \\nUpdated testing in Appendix 2 and 2.1, \\nadded blinding table \\nAdded PBMC tests to Appendix 2, \\nremoved ORT11031 & ORT11032 per \\nBiomarin request \\nRemoved notation in Section 3.0 and \\n3.2 about PBMC being excluded from \\nthe lab file \\nRemoved notation about not validated \\ntesting from Section 2.1.b \\nRemoved duplicate test from Appendix \\n2 HCV RNA/656/HCVVLD as it already \\nexists under HCV RNA CAP/CTM2 \\nAdded missing tests to Appendix 2 \\n1.Factor VIII Inhibitor/550/FVIIIIN \\n2.AAV5 Antibody Confirmation/627/ \\nAAV5ABC \\n \\nChanged transfer frequency to daily \\nAdded 5-10 business day note regarding \\nreconciliation \\nUpdated Visit Table to align with \\ncurrent DTS \\nAdded the new test - Thrombin \\nGeneration Assay \\nUpdated visit mapping  \\nAdded Esoterix lab \\nAdded unmapped FVIII testing \\nLBSPID changed from 3 to 4 character \\nlength \\nAdded CNT550 to the already existing \\nmapping for CNT63. Added new test: \\nGlucose (Non-Fasting) RCT4515 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 12 of 43 \\n\\n\\x0c11.0 \\n\\n12.0 \\n\\n13.0 \\n\\n21JAN2020 \\n\\nCosmas Collins \\n\\n27FEB2020 \\n\\nCosmas Collins \\n\\nCDM \\n\\nCDM \\n\\n17MAR2020 \\n\\nGabrielle Stephens \\n\\nCLS \\n\\n14.0 \\n\\n06APR2020 \\n\\nGabrielle Stephens \\n\\nCLS \\n\\n15.0 \\n\\n05MAY2020 \\n\\nGabrielle Stephens \\n\\nCLS \\n\\n16.0 \\n\\n28AUG2020 \\n\\nAnn Mikhail \\n\\nCDM \\n\\n \\n\\n \\n\\nAdded (Fasting) to RCT11 \\nAdded the unmapped cytokine tests  \\nAdded the LBSCAT field  \\nUpdated the formatting of Appendix 21. \\nSo the text are not truncated.  \\nUpdated the FVIII testing to include \\nadministrative test code with unit \\nconversions.  \\nAdded ORT21666 to current C3A \\nmapping, ORT21147 to current Tryptase \\nmapping and CNT534 to current \\nHepatitis C mapping \\nUpdate layout to include LBTPT  \\nUpdate CLS contact to Jennifer \\nFournier. \\nUpdated CNT353 for lab test name and \\ncode; updated lab test names for \\nORT13974 and ORT18074   \\nUpdated section 2 to set up sFTP for \\nBloodworks data \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 13 of 43 \\n\\n\\x0cAPPENDIX 1 – Visit Names \\n\\nLab Visit Name (LABVISIT) \\n\\nVisit Description (FOLDERNAME) \\n\\nCovance Visit Name \\n\\nCovance PVC \\n\\nScreening \\nSmart Re-Screening \\n \\nBaseline  \\n \\n\\nDay 1 \\n\\nDAY 4 \\nDay 8 \\nWeek 2 (DAY 15) \\nWeek 3 (DAY 22) \\nWeek 4 (DAY 29) \\nWeek 5 (DAY 36) \\nWeek 6 (DAY 43) \\nWeek 7 (DAY 50) \\nWeek 8 (DAY 57) \\nWeek 9 (DAY 64) \\nWeek 10 (DAY 71) \\nWeek 11 (DAY 78) \\nWeek 12 (DAY 85) \\nWeek 13 (DAY 92) \\nWeek 14 (DAY 99) \\nWeek 15 (DAY 106) \\nWeek 16 (DAY 113) \\nWeek 17 (DAY 120) \\nWeek 18 (DAY 127) \\nWeek 19 (DAY 134) \\nWeek 20 (DAY 141) \\nWeek 21 (DAY 148) \\nWeek 22 (DAY 155) \\nWeek 23 (DAY 162) \\nWeek 24 (DAY 169) \\nWeek 25 (DAY 176) \\nWeek 26 (DAY 183) \\nWeek 27 (DAY 190) \\nWeek 28 (DAY 197) \\nWeek 29 (DAY 204) \\nWeek 30 (DAY 211) \\nWeek 31 (DAY 218) \\nWeek 32 (DAY 225) \\nWeek 33 (DAY 232) \\n\\nScreening \\nSmart Re-Screening \\n \\nBaseline  \\n \\nDay 1 \\n \\nDAY 4 \\nDay 8 \\nWeek 2  \\nWeek 3  \\nWeek 4  \\nWeek 5  \\nWeek 6  \\nWeek 7  \\nWeek 8  \\nWeek 9  \\nWeek 10  \\nWeek 11  \\nWeek 12  \\nWeek 13  \\nWeek 14  \\nWeek 15  \\nWeek 16  \\nWeek 17  \\nWeek 18  \\nWeek 19  \\nWeek 20  \\nWeek 21  \\nWeek 22  \\nWeek 23  \\nWeek 24  \\nWeek 25  \\nWeek 26  \\nWeek 27  \\nWeek 28  \\nWeek 29  \\nWeek 30  \\nWeek 31  \\nWeek 32  \\nWeek 33  \\n\\nScreening \\n\\nSCRN \\n\\nSmart Rescreening \\n\\nRESCRN \\n\\nBaseline \\nBMN 270 Infusion (Day \\n1) \\nDay 4 \\nDay 8 \\nWeek 2 \\nWeek 3 \\nWeek 4 \\nWeek 5 \\nWeek 6 \\nWeek 7 \\nWeek 8 \\nWeek 9 \\nWeek 10 \\nWeek 11 \\nWeek 12 \\nWeek 13 \\nWeek 14 \\nWeek 15 \\nWeek 16 \\nWeek 17 \\nWeek 18 \\nWeek 19 \\nWeek 20 \\nWeek 21 \\nWeek 22 \\nWeek 23 \\nWeek 24 \\nWeek 25 \\nWeek 26 \\nWeek 27 \\nWeek 28 \\nWeek 29 \\nWeek 30 \\nWeek 31 \\nWeek 32 \\nWeek 33 \\n\\nBASE \\n\\nD1 \\nD4 \\nD8 \\nW2 \\nW3 \\nW4 \\nW5 \\nW6 \\nW7 \\nW8 \\nW9 \\nW10 \\nW11 \\nW12 \\nW13 \\nW14 \\nW15 \\nW16 \\nW17 \\nW18 \\nW19 \\nW20 \\nW21 \\nW22 \\nW23 \\nW24 \\nW25 \\nW26 \\nW27 \\nW28 \\nW29 \\nW30 \\nW31 \\nW32 \\nW33 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 14 of 43 \\n\\n\\x0cLab Visit Name (LABVISIT) \\n\\nVisit Description (FOLDERNAME) \\n\\nCovance Visit Name \\n\\nCovance PVC \\n\\nWeek 34 (DAY 239) \\nWeek 35 (DAY 246) \\nWeek 36 (DAY 253) \\nWeek 38 (DAY 267) \\nWeek 40 (DAY 281) \\nWeek 42 (DAY 295) \\nWeek 44 (DAY 309) \\nWeek 46 (DAY 323) \\nWeek 48 (DAY 337) \\nWeek 50 (DAY 351) \\nWeek 52 (DAY 365) \\n\\nWeek 34  \\nWeek 35  \\nWeek 36  \\nWeek 38  \\nWeek 40  \\nWeek 42  \\nWeek 44  \\nWeek 46  \\nWeek 48  \\nWeek 50  \\nWeek 52  \\n\\nYear 2 Week 56 \\n\\nWeek 56 \\n\\nYear 2 Week 60 \\n\\nYear 2 Week 64 \\n\\nYear 2 Week 65 \\n\\nYear 2 Week 68 \\n\\nYear 2 Week 72 \\n\\nYear 2 Week 76 \\n\\nYear 2 Week 80 \\nYear 2 Week 84 \\n\\nYear 2 Week 88 \\n\\nYear 2 Week 92 \\nYear 2 Week 96 \\nYear 2 Week 100 \\nYear 2 Week 104 \\n\\nYear 2 Week 110 \\n\\nYear 2 Week 116 \\n\\nYear 3 Week 122 \\n\\nYear 3 Week 128 \\n\\nYear 3 Week 134 \\n\\nYear 3 Week 140 \\n\\nYear 3 Week 146 \\n\\nWeek 60 \\n\\nWeek 64 \\n\\nWeek 65 \\n\\nWeek 68 \\n\\nWeek 72 \\n\\nWeek 76 \\n\\nWeek 80 \\nWeek 84 \\n\\nWeek 88 \\n\\nWeek 92 \\nWeek 96 \\nWeek 100 \\nWeek 104 \\n\\nWeek 110 \\n\\nWeek 116 \\n\\nWeek 122 \\n\\nWeek 128 \\n\\nWeek 134 \\n\\nWeek 140 \\n\\nWeek 146 \\n\\nWeek 34 \\nWeek 35 \\nWeek 36 \\nWeek 38 \\nWeek 40 \\nWeek 42 \\nWeek 44 \\nWeek 46 \\nWeek 48 \\nWeek 50 \\nWeek 52 \\n\\nYear 2 Q4W \\n\\nYear 2 Q4W \\n\\nYear 2-5 Q12W \\n\\nYear 2 Week 65 \\n\\nYear 2 Q4W \\n\\nYear 2 Q4W \\n\\nYear 2-5 Q12W \\nYear 2 Q4W \\nYear 2 Q4W \\n\\nYear 2-5 Q12W \\nYear 2 Q4W \\nYear 2 Q4W \\nYear 2 Q4W \\nYear 2 Week 104 \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\nYear 3-5 Q6W \\n\\nW34 \\nW35 \\nW36 \\nW38 \\nW40 \\nW42 \\nW44 \\nW46 \\nW48 \\nW50 \\nW52 \\nY2-W56 \\n\\n \\nY2-W60 \\n\\nY2-W64 \\n\\nY2-W65 \\nY2-W68 \\n\\nY2-W72 \\n\\nY2-W76 \\n\\nY2-W80 \\nY2-W84 \\nY2-W88 \\n\\nY2-W92 \\nY2-W96 \\nY2-W100 \\n\\nY2-W104 \\nY3-W110 \\n\\nY3-W116 \\n\\nY3-W122 \\n\\nY3-W128 \\n\\nY3-W134 \\n\\nY3-W140 \\n\\nY3-W146 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 15 of 43 \\n\\n\\x0cLab Visit Name (LABVISIT) \\n\\nVisit Description (FOLDERNAME) \\n\\nCovance Visit Name \\n\\nCovance PVC \\n\\nYear 3 Week 152 \\nYear 3 Week 156 \\n\\nYear 3 Week 162 \\n\\nYear 3 Week 168 \\n\\nYear 4 Week 174 \\n\\nYear 4 Week 180 \\n\\nYear 4 Week 182 \\n\\nYear 4 Week 186 \\n\\nYear 4 Week 192 \\n\\nYear 4 Week 198 \\nYear 4 Week 204 \\nYear 4 Week 208 \\n\\nYear 4 Week 214 \\n\\nYear 4 Week 220 \\n\\nYear 4 Week 226 \\n\\nYear 4 Week 232 \\n\\nYear 5 Week 238 \\n\\nYear 5 Week 244 \\n\\nYear 5 Week 247 \\nYear 4 Week 250 \\nYear 5 Week 256 \\nYear 5 Week 260 \\nETV \\n\\nWeek 152 \\nWeek 156 \\nWeek 162 \\n\\nWeek 168 \\n\\nWeek 174 \\n\\nWeek 180 \\n\\nWeek 182 \\nWeek 186 \\n\\nWeek 192 \\n\\nWeek 198 \\nWeek 204 \\nWeek 208 \\nWeek 214 \\n\\nWeek 220 \\n\\nWeek 226 \\n\\nWeek 232 \\n\\nWeek 238 \\n\\nWeek 244 \\n\\nWeek 247 \\nWeek 250 \\nWeek 256 \\nWeek 260 \\n\\nEarly Termination \\n\\nRetest  \\n\\nUnscheduled \\n\\nUnscheduled  \\n\\nUnscheduled \\n\\nSteroid Treatment  Week 6  Unscheduled \\n\\nPost Steroid  Week 1 \\nPost Steroid Week 2 \\nPost Steroid Week 3 \\nPost Steroid Week 4 \\n\\nUnscheduled \\nUnscheduled \\nUnscheduled \\nUnscheduled \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nYear 3-5 Q6W \\nYear 3 Week 156 \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\nYear 4 Week 182 \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\nYear 3-5 Q6W \\nYear 3-5 Q6W \\nYear 4 Week 208 \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\n\\nYear 3-5 Q6W \\n\\nYear 2-5 Q12W \\nYear 5 Week 247 \\nYear 3-5 Q6W \\nYear 3-5 Q6W \\nYear 5 Week 260 \\nEarly Termination Visit \\nSafety Retest \\n\\n \\nUnscheduled 2 \\n\\nSteroid Treatment \\nWeek 6 \\nPost Steroid Week 1 \\nPost Steroid Week 2 \\nPost Steroid Week 3 \\nPost Steroid Week 4 \\n\\nY3-W152 \\n\\nY3-W156 \\nY4-W162 \\n\\n \\nY4-W168 \\n\\nY4-W174 \\n\\nY4-W180 \\n\\nY4-W182 \\nY4-W186 \\n\\nY4-W192 \\n\\nY4-W198 \\nY4-W204 \\n\\nY4-W208 \\nY4-W214 \\n\\nY5-W220 \\n\\nY4-W226 \\n\\nY5-W232 \\n\\nY4-W238 \\n\\nY5-W244 \\n\\nY5-W247 \\nY4-W250 \\nY5-W256 \\n\\nY5-W260 \\nETV \\n\\nPreviously \\nscheduled visit \\n\\nUNSCHED \\n\\nST-W6 \\nPST-W1 \\nPST-W2 \\nPST-W3 \\nPST-W4 \\n\\nPage 16 of 43 \\n\\n\\x0cLab Visit Name (LABVISIT) \\n\\nVisit Description (FOLDERNAME) \\n\\nCovance Visit Name \\n\\nCovance PVC \\n\\nPost Steroid Week 13 \\nUnscheduled Vector \\nShedding \\nHypersensitivity Reaction \\nVisit \\n\\nUnscheduled \\n\\nUnscheduled \\n\\nUnscheduled \\n\\nLFT and FVIII Monitoring \\n\\nUnscheduled \\n\\nYear # Week ## \\nYear # Week ### \\nYear # Week ## \\nYear # Week ### \\nYear # Week #  \\nYear # Week # \\nYear # Week ## \\nABO TYPING \\n\\n \\n\\nWeek ## \\nWeek ### \\nWeek ## \\nWeek ### \\nWeek # \\nWeek # \\nWeek ## \\nUnscheduled \\n \\n\\nPost Steroid Week 13 \\nUnscheduled Vector \\nShedding \\nHypersensitivity \\nReaction \\nLFT and FVIII \\nMonitoring \\nPatient Home Health \\nYear 1 \\nPatient Home Health \\nYear 2-5 \\nPatient Home Health \\nYear 1 and Patient \\nHome Health Year 2-5 \\nABO TYPING \\n\\nPST-W13 \\n\\nUN-VSH \\n\\nHYPER \\nY_-W_ _-MO \\nY_-W_ _ _-MO \\nY_-W_ _  \\nY_-W_ _ _ \\nY_-W_ _    \\nY_-W_ _ _ \\nY_-W0_ \\nY_-W00_ \\nY_-W0_ _ \\nABOTYPING \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 17 of 43 \\n\\n\\x0cAPPENDIX 2 – Laboratory Test Identifiers, Short and Long Names for unblinded file \\n\\nLab Category \\n\\n(LBCAT) \\n\\nChemistry \\n\\n \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nChemistry \\n\\nLiver Function \\nTesting \\n\\n101 \\n\\n102 \\n\\nALB \\n\\nAlbumin \\n\\nAlbumin \\n\\nALP \\n\\nAlkaline Phosphatase  Alkaline \\n\\nphosphatase \\n\\nRCT3088 \\n\\nRCT1407 \\n\\nChemistry \\n\\nLiver Function \\nTesting \\n\\n103 \\n\\nALT \\n\\nChemistry \\n\\nLiver Function \\nTesting \\n\\n104 \\n\\nAST \\n\\nAlanine \\nAminotransferase \\n\\nAspartate \\nAminotransferase \\n\\nALT (SGPT) \\n\\nRCT4 \\n\\nAST (SGOT) \\n\\nRCT5 \\n\\nChemistry \\n\\nChemistry \\n\\nLiver \\nDYSFUNCTION \\n\\nLiver \\nDYSFUNCTION \\n\\nChemistry \\n\\nCreatinine TOX \\nGrade \\n\\nChemistry \\n\\nChemistry \\n\\n \\n\\n \\n\\nChemistry \\n\\nElectrolyte \\npanel \\n\\nChemistry \\n\\n \\n\\nChemistry \\n\\nLiver Function \\nTesting \\n\\nChemistry \\n\\n \\n\\nChemistry \\n\\nLiver Function \\nTesting \\n\\nChemistry \\n\\n \\n\\nChemistry \\n\\nLiver Function \\nTest \\n\\nChemistry \\n\\n \\n\\nChemistry \\n\\nElectrolyte \\npanel \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n763 \\n\\nLDTBIL \\n\\nLiver DYSFUNCTION \\n(TBIL) \\n\\nLiver DYSFUNCTION \\n(TBIL) \\n\\nAMT36151 \\n\\n764 \\n\\nLDINR \\n\\nLiver DYSFUNCTION \\n(INR) \\n\\nLiver DYSFUNCTION \\n(INR) \\n\\nAMT36150 \\n\\n765 \\n\\nCRTGR \\n\\nCreatinine TOX Grade  Creatinine TOX \\n\\nAMT36152 \\n\\n105 \\n\\n106 \\n\\n107 \\n\\n109 \\n\\n110 \\n\\n119 \\n\\n111 \\n\\n113 \\n\\n115 \\n\\n116 \\n\\n117 \\n\\nGrade \\n\\nBUN \\n\\nBlood Urea Nitrogen  BUN \\n\\nCA \\n\\nCL \\n\\nCalcium \\n\\nChloride \\n\\nCalcium \\n\\nChloride \\n\\nRCT6 \\n\\nRCT183 \\n\\nRCT18 \\n\\nCREAT \\n\\nCreatinine \\n\\nCreatinine \\n\\nRCT392 \\n\\nBILDIR \\n\\nDirect Bilirubin \\n\\nDirect bilirubin \\n\\nRCT29 \\n\\nBILI \\n\\nBilirubin \\n\\nTotal Bilirubin \\n\\nGGT \\n\\nGamma Glutamyl \\nTransferase \\n\\nGGT \\n\\nGLUC \\n\\nGlucose (FASTING) \\n\\nGlucose \\n\\nLDH \\n\\nLactate \\nDehydrogenase \\n\\nLDH \\n\\nPHOS \\n\\nPhosphate \\n\\nPhosphorus \\n\\nK \\n\\nPotassium \\n\\nPotassium \\n\\nRCT1 \\n\\nRCT3 \\n\\nRCT11 \\n\\nRCT1408 \\n\\nRCT9 \\n\\nRCT16 \\n\\nPage 18 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nChemistry \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nElectrolyte \\nPanel \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n118 \\n\\nShort Name \\n(LBTESTCD) \\nSODIUM \\n\\nLab Test \\n\\nLab Test Name \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nSodium \\n\\nSodium \\n\\nRCT15 \\n\\nChemistry \\n\\nChemistry \\n\\nChemistry \\n\\nChemistry \\n\\nChemistry \\n\\nChemistry \\n\\nChemistry \\n\\n \\n\\n \\n\\n \\n\\nFasting Lipid \\nPanel \\n\\nFasting Lipid \\nPanel \\n\\nFasting Lipid \\nPanel \\n\\nFasting Lipid \\nPanel \\n\\nChemistry \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nHematology  Differential \\n\\ncell count \\n\\nPROT \\n\\nProtein \\n\\nTotal protein \\n\\nURATE \\n\\nUrate \\n\\nUric acid \\n\\nRCT12 \\n\\nRCT8 \\n\\nCK \\n\\nCreatine Kinase \\n\\nCreatine Kinase \\n\\nRCT14 \\n\\n121 \\n\\n126 \\n\\n144 \\n\\n794 \\n\\nHDL3 \\n\\nHDL-Cholesterol \\nSubclass 3 \\n\\nDirect HDL-C 3rd \\nGeneration \\n\\n128 \\n\\nLDL \\n\\nLDL Cholesterol \\n\\nLDL Chol-\\nFriedewald 3rd \\n\\nRCT1684 \\n\\nRCT1685 \\n\\n147 \\n\\nTRIG \\n\\nTriglycerides \\n\\nTriglycerides (GPO) \\n\\nRCT19 \\n\\n549 \\n\\nCHOLH \\n\\nCholesterol (High \\nPerformance) \\n\\nCholesterol (High \\nPerformance) \\n\\nRCT20 \\n\\n1197 \\n\\nGLUCNFST  Glucose (Non-Fasting) \\n\\nGlucose \\n\\nRCT4515 \\n\\n201 \\n\\n202 \\n\\n203 \\n\\n204 \\n\\n210 \\n\\n211 \\n\\nHGB \\n\\nHemoglobin \\n\\nHemoglobin \\n\\nHMT40 \\n\\nHCT \\n\\nHematocrit \\n\\nHematocrit \\n\\nWBC \\n\\nLeukocytes \\n\\nWBC Count \\n\\nRBC \\n\\nErythrocytes \\n\\nRBC Count \\n\\nHMT2 \\n\\nHMT7 \\n\\nHMT3 \\n\\nPLAT \\n\\nPlatelets \\n\\nPlatelet Count \\n\\nHMT13 \\n\\nNEUT \\n\\nNeutrophils \\n\\nNeutrophils \\n\\nHMT8 \\n\\nHematology  Differential \\n\\n212 \\n\\nLYM \\n\\nLymphocytes \\n\\nLymphocyte Count \\n\\nHMT9 \\n\\ncell count \\n\\nHematology  Differential \\n\\n213 \\n\\nMONO  Monocytes \\n\\nMonocyte Count \\n\\nHMT10 \\n\\ncell count \\n\\nHematology  Differential \\n\\n214 \\n\\nBASO \\n\\nBasophil Count \\n\\nBasophil Count \\n\\nHMT12 \\n\\ncell count \\n\\nHematology  Differential \\n\\n215 \\n\\nEOS \\n\\nEosinophils \\n\\nEosinophil Count \\n\\nHMT11 \\n\\ncell count \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 19 of 43 \\n\\n\\x0c(LBCAT) \\n\\nLab Category \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\nHematology  Differential \\n\\ncell count \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\n216 \\n\\nNEUTB \\n\\nNeutrophils Band \\nForm \\n\\nNeutrophil Band \\nCount \\n\\nHMT20 \\n\\nHematology  Differential \\n\\n221 \\n\\nNEUTLE \\n\\ncell count \\n\\nHematology  Differential \\n\\n222 \\n\\nLYMLE \\n\\ncell count \\n\\nNeutrophils/Leukocyt\\nes \\n\\nLymphocytes/Leukoc\\nytes \\n\\nNeutrophils % \\n\\nHMT15 \\n\\nLymphocytes % \\n\\nHMT16 \\n\\nHematology  Differential \\n\\n223 \\n\\nMONOLE  Monocytes/Leukocyt\\n\\nMonocytes % \\n\\nHMT17 \\n\\ncell count \\n\\nes \\n\\nHematology  Differential \\n\\n224 \\n\\nBASOLE \\n\\nBasophils/Leukocytes  Basophils % \\n\\nHMT19 \\n\\ncell count \\n\\nHematology  Differential \\n\\n225 \\n\\nEOSLE \\n\\ncell count \\n\\nEosinophils/Leukocyt\\nes \\n\\nEosinophils % \\n\\nHMT18 \\n\\nHematology  Differential \\n\\n226 \\n\\ncell count \\n\\nNEUTBLE  Neutrophils Band \\nForm / Leukocytes \\n\\nNeutrophil Bands % \\n\\nHMT21 \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n205 \\n\\nMCV \\n\\nEry. Mean \\nCorpuscular Volume \\n\\nEry. Mean \\nCorpuscular Volume \\n\\nHMT4 \\n\\n232 \\n\\nRBCMORPH  RBC Morphology \\n\\nRBC Morphology \\n\\nHMT71 \\n\\n206 \\n\\nMCH \\n\\nEry. Mean \\nCorpuscular \\nHemoglobin \\n\\nEry. Mean \\nCorpuscular \\nHemoglobin \\n\\nHMT100 \\n\\n250 \\n\\nMETAMY  Metamyelocytes \\n\\nMetamyelocyte \\n(abs) \\n\\nHMT93 \\n\\n249 \\n\\n237 \\n\\nMYCY  Myelocytes \\n\\nMyelocyte (abs) \\n\\nHMT92 \\n\\nMYCYLE  Myelocytes % \\n\\nMyelocyte (%) \\n\\nHMT68 \\n\\n243 \\n\\nMETAMYL\\n\\nMetamyelocytes %  Metamyelocyte (%) \\n\\nHMT69 \\n\\nE \\n\\n291 \\n\\nCBCCOMM\\n\\nCBC Comment % \\n\\nCBC Comment: (%) \\n\\nHMT51 \\n\\nP \\n\\n235 \\n\\nBLASTLE \\n\\nBlasts % \\n\\nBlasts (%) \\n\\nHMT97 \\n\\n281 \\n\\nLYMMCELY  Lymphoma Cell % \\n\\nLymphoma Cell (%) \\n\\nHMT55 \\n\\n234 \\n\\nPRLYMLE \\n\\nProlymphocytes % \\n\\nProlymphocyte (%) \\n\\nHMT56 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 20 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\n289 \\n\\nSEZCELY \\n\\nSezary Cell % \\n\\nSezary Cell (%) \\n\\nHMT57 \\n\\n279 \\n\\nBLSTLMLY \\n\\nLymphocyte, \\nImmunoblastic % \\n\\nLymphocyte, \\nImmunoblastic (%) \\n\\n280 \\n\\nLYMPLLY \\n\\nLymphocyte, \\nPlasmacytoid % \\n\\nLymphocyte, \\nPlasmacytoid (%) \\n\\n273 \\n\\nLYMRCTLY \\n\\nLymphocyte, \\nReactive % \\n\\nLymphocyte, \\nReactive (%) \\n\\nHMT59 \\n\\nHMT60 \\n\\nHMT61 \\n\\n278 \\n\\nLYMBLLY \\n\\nLymphoblast % \\n\\nLymphoblast-QT (%) \\n\\nHMT62 \\n\\n233 \\n\\nLYMATLE  Atypical \\n\\nlymphocytes % \\n\\nAtypical \\nLymphocytes (%) \\n\\nHMT96 \\n\\n239 \\n\\nPROMONLE  Promonocytes % \\n\\nPromonocyte (%) \\n\\nHMT63 \\n\\n283 \\n\\nMONOBLLE  Monoblast % \\n\\nMonoblast-QT (%) \\n\\nHMT64 \\n\\n284 \\n\\nMONOIMLE  Monocyte, \\n\\n276 \\n\\nEOSIMLE \\n\\nImmature % \\n\\nEosinophil, \\nImmature % \\n\\nMonocyte, \\nImmature (%) \\n\\nEosinophil, \\nImmature (%) \\n\\nHMT65 \\n\\nHMT49 \\n\\n275 \\n\\nBASOIMLE  Basophil, \\n\\nImmature % \\n\\nBasophil, Immature \\n(%) \\n\\nHMT48 \\n\\n282 \\n\\nMLIGCEBC  Malignant Cell, \\n\\n286 \\n\\nPLSPCELY \\n\\nNOS % \\n\\nPlasma Cell \\nPrecursor % \\n\\n287 \\n\\nPLSIMCLY  Plasma Cell \\nImmature % \\n\\nMalignant Cell, NOS \\n(%) \\n\\nHMT50 \\n\\nPlasma Cell \\nPrecursor (%) \\n\\nPlasma Cell, \\nImmature (%) \\n\\nHMT52 \\n\\nHMT53 \\n\\n288 \\n\\nPLSMCELY  Plasma Cell, \\n\\nMature % \\n\\nPlasma Cell, Mature \\n(%) \\n\\nHMT54 \\n\\n277 \\n\\nHRYCELY  Hairy Cell % \\n\\nHairy Cell (%) \\n\\nHMT58 \\n\\n236 \\n\\nPROMYLE  Promyelocytes % \\n\\nPromyelocyte (%) \\n\\nHMT67 \\n\\n274 \\n\\nRBCNUCLE  Nucleated RBC % \\n\\nNucleated Red \\nBlood Cells (%) \\n\\nHMT70 \\n\\n248 \\n\\nBLAST \\n\\nBlasts \\n\\nBlasts (abs) \\n\\nHMT94 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 21 of 43 \\n\\n\\x0cLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\n262 \\n\\nSEZCE \\n\\nSezary Cell \\n\\nSezary Cell (abs) \\n\\nHMT72 \\n\\n261 \\n\\nLYMMCE \\n\\nLymphoma Cell \\n\\n255 \\n\\nPROLYM \\n\\nProlymphocytes \\n\\nLymphoma Cell \\n(abs) \\n\\nProlymphocyte \\n(abs) \\n\\nHMT80 \\n\\nHMT81 \\n\\n257 \\n\\nBLASTLM \\n\\nLymphocyte, \\nImmunoblastic \\n\\nLymphocyte, \\nImmunoblastic (abs) \\n\\nHMT83 \\n\\n258 \\n\\nLYMPL \\n\\n259 \\n\\nLYMRCT \\n\\nLymphocyte, \\nPlasmacytoid \\n\\nLymphocyte, \\nReactive \\n\\n679 \\n\\nBLSTLY \\n\\nLymphoblasts \\n\\nLymphocyte, \\nPlasmacytoid (abs) \\n\\nLymphocyte, \\nReactive (abs) \\n\\nLymphoblast-QT \\n(abs) \\n\\n254 \\n\\nLYMAT \\n\\nAtypical \\nlymphocytes \\n\\nAtypical \\nLymphocytes (abs) \\n\\nHMT84 \\n\\nHMT85 \\n\\nHMT86 \\n\\nHMT95 \\n\\n256 \\n\\nPROMONO  Promonocytes \\n\\nPromonocyte (abs) \\n\\nHMT87 \\n\\nMONOBL  Monoblast \\n\\nMonoblast-QT (abs) \\n\\nHMT88 \\n\\n263 \\n\\n264 \\n\\nMONOIM  Monocyte, \\nImmature \\n\\n265 \\n\\nEOSIM \\n\\n266 \\n\\nBASOIM \\n\\nEosinophil, \\nImmature \\n\\nBasophil, \\nImmature \\n\\n270 \\n\\nMLIGCE  Malignant Cell, \\n\\n267 \\n\\nPLSPCE \\n\\n268 \\n\\nPLSIMCE \\n\\n269 \\n\\nPLSMCE \\n\\nNOS \\n\\nPlasma Cell \\nPrecursor \\n\\nPlasma Cell, \\nImmature \\n\\nPlasma Cell, \\nMature \\n\\nMonocyte, \\nImmature (abs) \\n\\nEosinophil, \\nImmature (abs) \\n\\nBasophil, Immature \\n(abs) \\n\\nHMT89 \\n\\nHMT75 \\n\\nHMT74 \\n\\nMalignant Cell, NOS \\n(abs) \\n\\nHMT76 \\n\\nPlasma Cell \\nPrecursor (abs) \\n\\nPlasma Cell, \\nImmature (abs) \\n\\nHMT77 \\n\\nHMT78 \\n\\nPlasma Cell, Mature \\n(abs) \\n\\nHMT79 \\n\\nLab Category \\n\\n(LBCAT) \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n271 \\n\\nHAIRYCE  Hairy Cell \\n\\nHairy Cell (abs) \\n\\nHMT82 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 22 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nHematology \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\nUrinalysis \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\n238 \\n\\nRBCNUC  Nucleated RBC Count  Nucleated Red \\n\\nHMT98 \\n\\n290 \\n\\nCBCCOMM  CBC Comment \\n\\n285 \\n\\nMYBLALE  Myeloblast % \\n\\n272 \\n\\nMYBLA  Myeloblast \\n\\nBlood Cells (abs) \\n\\nCBC Comment: \\n(abs) \\n\\nMyeloblast-QT % \\n(abs) \\n\\nMyeloblast-QT  \\n(abs) \\n\\nHMT99 \\n\\nHMT66 \\n\\nHMT90 \\n\\n251 \\n\\nPROMY \\n\\nPromyelocytes \\n\\nPromyelocyte  (abs) \\n\\nHMT91 \\n\\n301 \\n\\nAPPEARU  Appearance \\n\\nUrine Clarity \\n\\nUAT13 \\n\\n302 \\n\\n303 \\n\\nCOLORU \\n\\nColor \\n\\nPHU \\n\\nUrine pH \\n\\nColor \\n\\npH \\n\\n304 \\n\\nSPGRAVU \\n\\nSpecific Gravity \\n\\nSpecific Gravity \\n\\n305 \\n\\n306 \\n\\nPROTU \\n\\nUrine Protein \\n\\nProtein \\n\\nGLUCU \\n\\nUrine Glucose \\n\\nGlucose \\n\\n307 \\n\\nKETONESU  Urine Ketones \\n\\nKetones \\n\\n308 \\n\\nNITRITEU  Urine Nitrite \\n\\nNitrite \\n\\n335 \\n\\nOCCBLDU  Urine Occult Blood \\n\\nBlood \\n\\n317 \\n\\nBILIU \\n\\nUrine Bilirubin \\n\\nBilirubin \\n\\nUAT1 \\n\\nUAT3 \\n\\nUAT2 \\n\\nUAT49 \\n\\nUAT5 \\n\\nUAT6 \\n\\nUAT10 \\n\\nUAT43 \\n\\nUAT7 \\n\\n318 \\n\\nUROBILU  Urine Urobilinogen \\n\\nUrobilinogen \\n\\nUAT53 \\n\\nOther Tests  Coagulation \\n\\n231 \\n\\nAPTT \\n\\nOther Tests  Coagulation \\n\\n461 \\n\\nINR \\n\\nActivated Partial \\nThromboplastin Time \\n\\nAPTT \\n\\nProthrombin Intl. \\nNormalized Ratio \\n\\nINR \\n\\nOther Tests  Coagulation \\n\\n548 \\n\\nTT \\n\\nThrombin Time \\n\\nTT \\n\\nOther Tests  CRP \\n\\nOther Tests  Coagulation \\n\\n418 \\n\\n462 \\n\\nCRP \\n\\nC-Reactive Protein \\n\\nCRP \\n\\nPT \\n\\nProthrombin Time \\n\\nPT \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nCGT646 \\n\\nCGT564 \\n\\nCGT737, \\nCGT255 \\n\\nSCT3689 \\n\\nCGT283 \\n\\nPage 23 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nOther Tests  Factor VIII \\n\\n550 \\n\\nFVIIIIN \\n\\nFactor VIII Inhibitor \\n\\nInhibitor \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nFVIII INHIBITOR \\nLEVEL (EXP) \\n\\nORT17364 \\n\\n \\n\\nOther Tests  VWF \\n\\n745 \\n\\nVWF \\n\\nVon Willebrand \\nFactor \\n\\nVON WILLERBRAND \\nFACTOR \\n\\nORT17366 \\n\\nOther Tests  Blood Viral \\n\\n601 \\n\\nBLDVSHDS  Blood Viral Shedding \\n\\nShedding \\n\\nSCR \\n\\nOther Tests  Blood Viral \\n\\n602 \\n\\nBLDVSHDC  Blood Viral Shedding \\n\\nShedding \\n\\nCONF \\n\\nOther Tests  Blood Viral \\n\\n604 \\n\\nBLDVSHDQ  Blood Viral Shedding \\n\\nShedding \\n\\nQuantitative \\n\\nOther Tests  Urine Viral \\n\\n605 \\n\\nURNVSHDS  Urine Viral Shedding \\n\\nShedding \\n\\nSCR \\n\\nOther Tests  Urine Viral \\n\\n606 \\n\\nURNVSHDC  Urine Viral Shedding \\n\\nShedding \\n\\nCONF \\n\\nOther Tests  Urine Viral \\n\\n608 \\n\\nURNVSHDQ  Urine Viral Shedding \\n\\nShedding \\n\\nQuantitative \\n\\nBlood Viral \\nShedding SCR \\n\\nBlood Viral \\nShedding CONF \\n\\nBlood Viral \\nShedding \\nQuantitative \\n\\nUrine Viral \\nShedding SCR \\n\\nUrine Viral \\nShedding CONF \\n\\nUrine Viral \\nShedding \\nQuantitative \\n\\nCLT3548 \\n\\nCLT3550 \\n\\n \\n\\n \\n\\nCLT3549 \\n\\n \\n\\n \\n\\nCLT3551 \\n\\nCLT3553 \\n\\n \\n\\nCLT3552 \\n\\nOther Tests  Stool Viral \\nShedding \\n\\n609 \\n\\nSTLVSHDS \\n\\nStool Viral Shedding \\nSCR \\n\\nStool Viral Shedding \\nSCR \\n\\nCLT3554 \\n\\nOther Tests  Stool Viral \\nShedding \\n\\n610 \\n\\nSTLVSHDC  Stool Viral Shedding \\n\\nCONF \\n\\nStool Viral Shedding \\nCONF \\n\\nCLT3556 \\n\\n \\n\\nOther Tests  Stool Viral \\nShedding \\n\\n612 \\n\\nSTLVSHDQ  Stool Viral Shedding \\n\\nQuantitative \\n\\nStool Viral Shedding \\nQuantitative \\n\\nCLT3555 \\n\\nOther Tests  Saliva Viral \\n\\n613 \\n\\nSLVVSHDS  Saliva Viral Shedding \\n\\nShedding \\n\\nSCR \\n\\nOther Tests  Saliva Viral \\n\\n614 \\n\\nSLVVSHDC  Saliva Viral Shedding \\n\\nShedding \\n\\nCONF \\n\\nOther Tests  Saliva Viral \\n\\n616 \\n\\nSLVVSHDQ  Saliva Viral Shedding \\n\\nShedding \\n\\nQuantitative \\n\\nSaliva Viral \\nShedding SCR \\n\\nSaliva Viral \\nShedding CONF \\n\\nSaliva Viral \\nShedding \\nQuantitative \\n\\nCLT3560 \\n\\nCLT3562 \\n\\n \\n\\n \\n\\nCLT3561 \\n\\n \\n\\n \\n\\nPage 24 of 43 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n\\x0c(LBCAT) \\n\\nLab Category \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\nOther Tests  Semen Viral \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n617 \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\nSMNVSHDS  Semen Viral Shedding \\n\\n(LBTEST) \\n\\nShedding \\n\\nSCR \\n\\nOther Tests  Semen Viral \\n\\n618 \\n\\nSMNVSHDC  Semen Viral Shedding \\n\\nShedding \\n\\nCONF \\n\\nOther Tests  Semen Viral \\n\\n620 \\n\\nSMNVSHDQ  Semen Viral Shedding \\n\\nShedding \\n\\nQuantitative \\n\\nOther Tests  AAV5 Antibody \\nScreening - Pre \\n\\n811 \\n\\nAAV5ABSA  AAV5 Antibody \\n\\nScreening (ARUP) \\n\\n \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nSemen Viral \\nShedding SCR \\n\\nSemen Viral \\nShedding CONF \\n\\nSemen Viral \\nShedding \\nQuantitative \\n\\nAAV5 Antibody \\nScreening \\n\\nCLT3557 \\n\\nCLT3559 \\n\\n \\n\\n \\n\\nCLT3558 \\n\\n \\n\\n \\n\\nORT17830 \\n\\nOther Tests  AAV5 Antibody \\nConfirmation - \\nPost \\n\\n816 \\n\\nAAV5ABCE  AAV5 Antibody \\n\\nConfirmation \\n(Eurofins) \\n\\nAAV5 Antibody \\nConfirmation \\n\\nORT17523 \\n\\nOther Tests  AAV5 Antibody \\n\\n813 \\n\\nAAV5ABA  AAV5 Antibody \\n\\nAAV5 Antibody \\n\\nORT17831 \\n\\n- Pre \\n\\n(ARUP) \\n\\nOther Tests  AAV5 Antibody \\n\\n812 \\n\\nAAV5ABSE  AAV5 Antibody \\n\\nScreening - \\nPost \\n\\nScreening (Eurofins) \\n\\nAAV5 Antibody \\nScreening \\n\\nORT17522 \\n\\nOther Tests  AAV5 Antibody \\n\\n814 \\n\\nAAV5ABE  AAV5 Antibody \\n\\nAAV5 Antibody \\n\\nORT17524 \\n\\n- Post \\n\\n(Eurofins) \\n\\nOther Tests  PBMC \\n\\n631 \\n\\nPBMCBVOL  PBMC Blood Volume  PBMC Blood \\n\\nHMT14349 \\n\\nProcessing \\n\\nVolume \\n\\nOther Tests  PBMC \\n\\n632 \\n\\nPBMCCNT  PBMC Count \\n\\nPBMC Count \\n\\nHMT14350 \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n633 \\n\\nPBMCTOT  PBMC Total \\n\\nPBMC Total \\n\\nHMT14351 \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n634 \\n\\nPBMCAV \\n\\nPBMC Available \\n\\nPBMC Available \\n\\nHMT14352 \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n635 \\n\\nPBMCSVOL  PBMC Susp Volume \\n\\nPBMC Susp Volume  HMT14353 \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n636 \\n\\nPBMCVOL  PBMC Volume \\n\\nPBMC Volume \\n\\nHMT14354 \\n\\nProcessing \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 25 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nOther Tests  PBMC \\n\\nProcessing \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n637 \\n\\nShort Name \\n(LBTESTCD) \\nPBMCVNU\\n\\nM \\n\\nLab Test \\n\\nLab Test Name \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nNumber of PBMC \\nVials \\n\\nNumber of PBMC \\nVials \\n\\nHMT14355 \\n\\nOther Tests  PBMC \\n\\n638 \\n\\nPBMCV \\n\\nPBMC Vials \\n\\nPBMC Vials \\n\\nHMT14356 \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n771 \\n\\nPBMCPD \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n772 \\n\\nPBMCPT \\n\\nProcessing \\n\\nPBMC Processing \\nDate \\n\\nPBMC Processing \\nTime \\n\\nProcessing Date \\n\\nHMT14358 \\n\\nProcessing Time \\n\\nHMT14359 \\n\\nOther Tests  PBMC \\n\\n639 \\n\\nPBMCCOM  PBMC Comment \\n\\nPBMC Comment \\n\\nHMT14360 \\n\\nProcessing \\n\\nOther Tests  PBMC \\n\\n773 \\n\\nPBMCVIAB  PBMC Viability \\n\\nPBMC Viability \\n\\nHMT14357 \\n\\nProcessing \\n\\nOther Tests  DNA \\n\\n640 \\n\\nDNAA260  A260 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n641 \\n\\nDNAA280  A280 \\n\\nExtraction \\n\\nA260 \\n\\nA280 \\n\\nNAT5092 \\n\\nNAT5093 \\n\\nOther Tests  DNA \\n\\n642 \\n\\nDNAPUR \\n\\nPurity \\n\\nPurity \\n\\nNAT5094 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n643 \\n\\nDNAHVOL  Hydration Volume \\n\\nHydration Volume \\n\\nNAT5090 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n644 \\n\\nDNACON \\n\\nConcentration \\n\\nConcentration \\n\\nNAT5095 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n645 \\n\\nDNATOT \\n\\nTotal Yield \\n\\nTotal Yield \\n\\nNAT5096 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n646 \\n\\nDNAA1CON  Aliquot 1 \\n\\nExtraction \\n\\nConcentration \\n\\nAliquot 1 \\nConcentration \\n\\nNAT5097 \\n\\nOther Tests  DNA \\n\\n647 \\n\\nDNAA1VOL  Aliquot 1 Volume \\n\\nAliquot 1 Volume \\n\\nNAT5098 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n648 \\n\\nDNAA1YLD  Aliquot 1 Yield \\n\\nAliquot 1 Yield \\n\\nNAT5099 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n649 \\n\\nDNAA2CON  Aliquot 2 \\n\\nExtraction \\n\\nConcentration \\n\\nAliquot 2 \\nConcentration \\n\\nNAT5100 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 26 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nOther Tests  DNA \\n\\nExtraction \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n650 \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\nDNAA2VOL  Aliquot 2 Volume \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nAliquot 2 Volume \\n\\nNAT5101 \\n\\nOther Tests  DNA \\n\\n651 \\n\\nDNAA2YLD  Aliquot 2 Yield \\n\\nAliquot 2 Yield \\n\\nNAT5102 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n652 \\n\\nDNAA3CON  Aliquot 3 \\n\\nExtraction \\n\\nConcentration \\n\\nAliquot 3 \\nConcentration \\n\\nNAT5103 \\n\\nOther Tests  DNA \\n\\n653 \\n\\nDNAA3VOL  Aliquot 3 Volume \\n\\nAliquot 3 Volume \\n\\nNAT5104 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n654 \\n\\nDNAA3YLD  Aliquot 3 Yield \\n\\nAliquot 3 Yield \\n\\nNAT5105 \\n\\nExtraction \\n\\nOther Tests  DNA \\n\\n655 \\n\\nDNABILL \\n\\nBillable up to 10 mL \\n\\nBillable up to 10 mL \\n\\nNAT5091 \\n\\nExtraction \\n\\nOther Tests  HCV RNA \\n\\n656 \\n\\nHCVVLD \\n\\nHCV Viral Load \\n\\nHepatitis C RNA \\n\\nGET1885 \\n\\nOther Tests  HIV \\n\\n494 \\n\\nHIV1AB \\n\\nHIV-1 Antibody \\n\\nOther Tests  HIV \\n\\n495 \\n\\nHIV2AB \\n\\nHIV-2 Antibody \\n\\nOther Tests  HIV \\n\\n774 \\n\\nHIV1AG \\n\\nHIV-1 Antigen \\n\\nHIV-1 Ab \\nSupplemental, \\nGeenius \\n\\nHIV-2 Ab \\nSupplemental, \\nGeenius \\n\\nIMT1946 \\n\\nIMT1947 \\n\\nHIV ½ Ag/Ab Screen \\nSiemens \\n\\nCNT449 \\n\\nOther Tests  HIV \\n\\n776 \\n\\nHIVABI \\n\\nHIV Ab Interpretation  HIV Ab \\n\\nIMT1948 \\n\\nInterpretation, \\nGeenius \\n\\nOther Tests  HIV \\n\\n777 \\n\\nHIVABC \\n\\nHIV Ab Confirmation  HIV Ab \\n\\nSGT4 \\n\\nOther Tests  HIV \\n\\n778 \\n\\nHIV1RNAQ  HIV-1 RNA Qual \\n\\nConfirmation \\n\\nHIV-1 RNA \\nQual,EDTApl-335 \\n\\nORT11277 \\n\\nOther Tests  CD4 \\n\\n779 \\n\\nCD4DABS \\n\\nCD4 Dir Abs \\n\\nCD4 Dir Abs \\n\\nFCT6 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 27 of 43 \\n\\n\\x0c(LBCAT) \\n\\nLab Category \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\nOther Tests  Genotyping \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\n805 \\n\\nHLAAA1 \\n\\nHLA-A Allele 1 \\n\\nHLA-A \\n\\nORT17801 \\n\\nOther Tests  Genotyping \\n\\n878 \\n\\nHLAAA2 \\n\\nHLA-A Allele 2 \\n\\nHLA-A \\n\\nORT17802 \\n(update of \\nORT17801) \\n\\nOther Tests  Genotyping \\n\\n806 \\n\\nHLABA1 \\n\\nHLA-B Allele 1 \\n\\nHLA-B \\n\\nORT17803 \\n\\n \\n\\nOther Tests  Genotyping \\n\\n879 \\n\\nHLABA2 \\n\\nHLA-B Allele 2 \\n\\nHLA-B \\n\\nORT17804 \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n807 \\n\\nHLACA1 \\n\\nHLA-C Allele 1 \\n\\nHLA-C \\n\\nORT17805 \\n\\n \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n880 \\n\\nHLACA2 \\n\\nHLA-C Allele 2 \\n\\nHLA-C \\n\\nORT17806 \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n808 \\n\\nHLDRB1A1 \\n\\nHLA-DRB1 Allele 1 \\n\\nHLA-DRB1 \\n\\nORT17807 \\n\\n \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n881 \\n\\nHLDRB1A2 \\n\\nHLA-DRB1 Allele 2 \\n\\nHLA-DRB1 \\n\\nORT17808 \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n1261 \\n\\nHLDQA1A1 \\n\\nHLA-DQA1 Allele 1 \\n\\nHLA-DQA1 \\n\\nORT17811 \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n1262 \\n\\nHLDQA1A2 \\n\\nHLA-DQA1 Allele 2 \\n\\nHLA-DQA1 \\n\\nORT17812 \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n809 \\n\\nHLDQB1A1 \\n\\nHLA-DQB1 Allele 1 \\n\\nHLA-DQB1 \\n\\nORT17809 \\n\\n \\n\\n \\n\\n \\n\\nOther Tests  Genotyping \\n\\n882 \\n\\nHLDQB1A2 \\n\\nHLA-DQB1 Allele 2 \\n\\nHLA-DQB1 \\n\\nORT17810 \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 28 of 43 \\n\\n\\x0c(LBCAT) \\n\\nLab Category \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\nOther Tests  Genotyping \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n810 \\n\\nShort Name \\n(LBTESTCD) \\nHLDPB1A1 \\n\\n \\n\\nLab Test \\n\\nLab Test Name \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nHLA-DPB1 Allele 1 \\n\\nHLA-DPB1 \\n\\nORT24866 \\n\\nOther Tests  Genotyping \\n\\n883 \\n\\nHLDPB1A2 \\n\\nHLA-DPB1 Allele 2 \\n\\nHLA-DPB1 \\n\\nORT24867 \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n \\n\\n743 \\n\\nFVIIIABS \\n\\nFactor VIII Antibody \\nTiter Screen \\n\\nFactor VIII Antibody \\nTiter Screen \\n\\nORT17417 \\n\\n744 \\n\\nFVIIIABC \\n\\nFactor VIII Antibody \\nTiter Confirmation \\n\\nFactor VIII Antibody \\nTiter Confirmation \\n\\nORT17418 \\n\\n760 \\n\\nF8GENTYP  Factor VIII \\n\\nFVIII Genotyping \\n\\nORT17848 \\n\\nGenotyping \\n\\n441 \\n\\nHBSAG \\n\\nHepatitis B Surface \\nAntigen \\n\\nHepatitis B Surface \\nAntigen \\n\\nCNT63  \\nCNT550 \\n\\n761 \\n\\nHBVVLD \\n\\nHBV Viral Load \\n\\nHBV DNA \\nCAP/CTM2.0-Exp-\\nEDTA-CL \\n\\n442 \\n\\nHCAB \\n\\nHepatitis C Antibody  Hepatitis C \\n\\nAntibody \\n\\nHepatitis B Surface \\nAntibody, Qualitative \\n\\nanti-Hep B Surface \\nAg2 Qual \\n\\nGET1905 \\n\\nCNT350, \\nCNT534 \\n\\nCNT353 \\n\\n940 \\n\\nHBSABQ \\n\\n \\n\\n \\n\\n917 \\n\\nHBCTAB \\n\\nHepatitis B Core Total \\nAntibody \\n\\nHepatitis B Core \\nTotal \\n\\nCNT68 \\n\\n780 \\n\\nHBVDNAC  HBV DNA CAP/CTM2  HBV DNA CAP/CTM \\n\\nGET1884 \\n\\n2.0Dil-EDTA-CL \\n\\n782 \\n\\nFVIIIINH \\n\\nFVIII Inhibitor Level \\nRepeat \\n\\nFVIII Nijmegen \\nBethesda Titer \\n\\nORT17365 \\n\\n \\n\\n796 \\n\\nHCVRNAC  HCV RNA CAP/CTM2  HCV RNA \\n\\nGET1885 \\n\\nCAP/CTM2 \\n\\n785 \\n\\nAFVIIIAT \\n\\nAnti-Factor VIII \\nAntibody Titration \\n\\nAnti-Factor VIII \\nAntibody Titration \\n\\nORT17416 \\n\\nPage 29 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nOther Tests  Factor VIII SQ \\n\\n792 \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\nF8SQDNAS  FVIII SQ DNA,Sperm \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nFVIII SQ \\nDNA,Sperm(-80)-\\n466 \\n\\nCLT5004 \\n\\nOther Tests  Factor VIII SQ \\n\\n860 \\n\\nF8SQSPUG \\n\\nFVIII SQ DNA,Sperm \\nin ug \\n\\nFVIIISQDNA \\nug,Sperm(-80)-466 \\n\\nCLT5002 \\n\\n \\n\\nOther Tests  Factor VIII SQ \\n\\n861 \\n\\nF8SQSPML \\n\\nFVIII SQ DNA,Sperm \\nin mL \\n\\nFVIIISQDNA \\nmL,Sperm(-80)-466 \\n\\nCLT5003 \\n\\n \\n\\nOther Tests  Factor VIII \\n\\n550 \\n\\nFVIIIIN \\n\\nFactor VIII Inhibitor \\n\\nInhibitor \\n\\nFVIII \\nG8NH,NaCitpl‐ \\nLDT(‐70)104 \\n\\nORT10040 \\n\\nOther Tests  VWF \\n\\n745 \\n\\nVWF \\n\\nVon Willebrand \\nFactor \\n\\nvWF Antigen-\\nNaCitpl(-70)LDT104 \\n\\nORT13243 \\n\\nOther Tests \\n\\n \\n\\n868 \\n\\nHDRB1NEA \\n\\nHLA Typing DRB1 \\nNon-excluded alleles \\n\\nNon-Exc DRB1 \\nAll,EDTAwb-579RPT \\n\\nORT17813 \\n\\n \\n\\n \\n\\n \\n\\nOther Tests \\n\\n \\n\\n869 \\n\\nHDQB1NEA \\n\\nHLA Typing DQB1 \\nNon-excluded alleles \\n\\nNon-Exc DQB1 \\nAll,EDTAwb-579RPT \\n\\nORT17814 \\n\\n \\n\\n \\n\\n \\n\\nOther Tests \\n\\n \\n\\n870 \\n\\nHDPB1NEA \\n\\nHLA Typing DPB1 \\nNon-excluded alleles \\n\\nNon-Exc DPB1 \\nAll,EDTAwb-579RPT \\n\\nORT17815 \\n\\n \\n\\n \\n\\nOther Tests \\n\\n \\n\\n1300 \\n\\nHDQA1NEA  HLA Typing DQA1 \\n\\nNon-excluded alleles \\n\\n \\n\\nNon-Exc DQA1 All, \\nEDTAwb-579RPT \\n\\nORT24868 \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\n \\n\\n \\n\\n871 \\n\\nF8INT22 \\n\\n \\n\\n872 \\n\\nF8HGVST \\n\\n \\n\\n \\n\\nFVIII Genotyping \\nInversion Intron 22 \\n\\nInvInt22,EDTAwb(-\\n70)-LDT580RPT \\n\\nORT17847 \\n\\nFVIII Genotyping \\nHGVS Transcript \\n\\nHGVS Tra,EDTAwb(-\\n70)-LDT580RPT \\n\\nORT17849 \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 30 of 43 \\n\\n\\x0cLab Test \\n\\nLab Test Name \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nLab Category \\n\\n(LBCAT) \\n\\nOther Tests \\n\\n \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n873 \\n\\nShort Name \\n(LBTESTCD) \\nF8HGVSP \\n\\n \\n\\nFVIII Genotyping \\nHGVS Protein \\n\\nHGVS Pro,EDTAwb(-\\n70)-LDT580RPT \\n\\nORT17850 \\n\\n \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nImmunogeni\\n\\ncity \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n629 \\n\\nCAAV5A \\n\\n \\n\\nAAV5 Cell Based TI \\nActivity \\n\\nCAAV5ActNaCitpl(-\\n70)LDT539RPT \\n\\nORT18074 \\n\\n874 \\n\\nCAAV5T \\n\\nAAV5 Cell Based TI \\nTiter (TTR) \\n\\nCAAV5TtrNaCitpl(-\\n70)LDT539RPT \\n\\nORT18075 \\n\\n627 \\n\\nAAV5ABC  AAV5 Antibody \\n\\nConfirmation \\n\\nAAV5Conf,NaCitpl(-\\n70)LDT539RPT \\n\\nORT22096 \\n\\n915 \\n\\nFVIIIINE \\n\\nFactor VIII Inhibitor \\nExpedited \\n\\nFVIIINjBNaCitp(-\\n70)EXPLDT104PS \\n\\nORT19231, \\nORT17364 \\n\\n439 \\n\\nIGE \\n\\nImmunoglobulin E \\n\\nIgE \\n\\nCNT429 \\n\\n435 \\n\\nTRYPTASE  Tryptase \\n\\n447 \\n\\nC3 \\n\\nComplement C3 \\n\\n540 \\n\\nC3A \\n\\nComplement C3A \\n\\n437 \\n\\nC4 \\n\\nComplement 4 \\n\\n541 \\n\\nC5 \\n\\nComplement C5 \\n\\n542 \\n\\nC5A \\n\\nComplement C5A \\n\\nTryptase Level-160-\\nQT \\n\\nORT13955, \\nORT21147 \\n\\nComplement C3(-\\n70)EDTApl-160 \\n\\nORT13973 \\n\\nCompl C3a EDTApl(-\\n70)RUO160 \\n\\nORT14183, \\nORT21666 \\n\\nComplement C4(-\\n70)EDTApl-160 \\n\\nORT13974 \\n\\nCompC5, EDTApl(-\\n70)-LDT-160 \\n\\nORT18512 \\n\\nC5 Complement \\nAntigen-LDT-09 \\n\\nORT18487 \\n\\nImmunology  PBMC \\n\\n918 \\n\\nCollection \\n\\nMOCKIG  Mock (DMSO) IFNg  MockDMSOIFNgNa\\nHepwbRUO603RPT\\nPS \\n\\nORT21280 \\n\\nImmunology  PBMC \\n\\n919 \\n\\nAAV5P1IG  AAV5 pool 1 IFNg \\n\\nCollection \\n\\nAAV5p1 \\nIFNgNaHepwb-\\nRUO603RPTPS \\n\\nORT21281 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 31 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nImmunology  PBMC \\n\\nCollection \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n920 \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\nAAV5P2IG  AAV5 pool 2 IFNg \\n\\n(LBTEST) \\n\\nImmunology  PBMC \\n\\n921 \\n\\nF8P1IG \\n\\nFVIII Pool 1 IFNg \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n922 \\n\\nF8P2IG \\n\\nFVIII Pool 2 IFNg \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n923 \\n\\nF8P3IG \\n\\nFVIII Pool 3 IFNg \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n924 \\n\\nF8P4IG \\n\\nFVIII Pool 4 IFNg \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n925 \\n\\nPHAIG \\n\\nPHA IFNg \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n926 \\n\\nAAV5P1RT  AAV5 pool 1 Ratio \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n927 \\n\\nAAV5P2RT  AAV5 pool 2 Ratio \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n928 \\n\\nF8P1RT \\n\\nFVIII Pool 1 Ratio \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n929 \\n\\nF8P2RT \\n\\nFVIII Pool 2 Ratio \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n930 \\n\\nF8P3RT \\n\\nFVIII Pool 3 Ratio \\n\\nCollection \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nAAV5p2 \\nIFNgNaHepwb-\\nRUO603RPTPS \\n\\nFVIIIp1 \\nIFNgNaHepwbRUO6\\n03RPTPS \\n\\nFVIIIp2 \\nIFNgNaHepwbRUO6\\n03RPTPS \\n\\nFVIIIp3 \\nIFNgNaHepwbRUO6\\n03RPTPS \\n\\nFVIIIp4 \\nIFNgNaHepwbRUO6\\n03RPTPS \\n\\nPHA IFNg \\nNaHepwb-\\nRUO603RPTPS \\n\\nAAV5p1 \\nRatioNaHepwbRUO\\n603RPTPS \\n\\nAAV5p2 \\nRatioNaHepwbRUO\\n603RPTPS \\n\\nFVIIIp1 Rat \\nNaHepwbRUO603R\\nPTPS \\n\\nFVIIIp2 Rat \\nNaHepwbRUO603R\\nPTPS \\n\\nFVIIIp3 Rat \\nHepwbRUO603RPT\\nPS \\n\\nORT21282 \\n\\nORT21283 \\n\\nORT21284 \\n\\nORT21285 \\n\\nORT21286 \\n\\nORT21287 \\n\\nORT21288 \\n\\nORT21289 \\n\\nORT21290 \\n\\nORT21291 \\n\\nORT21292 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 32 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nImmunology  PBMC \\n\\n931 \\n\\nF8P4RT \\n\\nFVIII Pool 4 Ratio \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n932 \\n\\nPHART \\n\\nPHA Ratio \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n933 \\n\\nAAV5P1R  AAV5 pool 1 \\n\\nCollection \\n\\nResponse \\n\\nImmunology  PBMC \\n\\n934 \\n\\nAAV5P2R  AAV5 pool 2 \\n\\nCollection \\n\\nResponse \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nFVIIIp4 Rat \\nNaHepwbRUO603R\\nPTPS \\n\\nPHA Ratio \\nNaHepwb-\\nRUO603RPTPS \\n\\nAAV5p1 \\nRespNaHepwbRUO\\n603RPTPS \\n\\nAAV5p2 \\nRespNaHepwbRUO\\n603RPTPS \\n\\nORT21293 \\n\\nORT21294 \\n\\nORT21295 \\n\\nORT21296 \\n\\nImmunology  PBMC \\n\\n935 \\n\\nF8P1R \\n\\nFVIII Pool 1 Response  FVIIIp1 \\n\\nORT21297 \\n\\nCollection \\n\\nRespNeHepwbRUO\\n603RPTPS \\n\\nImmunology  PBMC \\n\\n936 \\n\\nF8P2R \\n\\nFVIII Pool 2 Response  FVIIIp2 \\n\\nORT21298 \\n\\nCollection \\n\\nRespNeHepwbRUO\\n603RPTPS \\n\\nImmunology  PBMC \\n\\n937 \\n\\nF8P3R \\n\\nFVIII Pool 3 Response  FVIIIp3 \\n\\nORT21299 \\n\\nCollection \\n\\nRespNeHepwbRUO\\n603RPTPS \\n\\nImmunology  PBMC \\n\\n938 \\n\\nF8P4R \\n\\nFVIII Pool 4 Response  FVIIIp4 \\n\\nORT21300 \\n\\nCollection \\n\\nImmunology  PBMC \\n\\n939 \\n\\nPHAR \\n\\nPHA Response \\n\\nCollection \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\n \\n\\n \\n\\n1198 \\n\\nTGAPH \\n\\nTGA Peak Height \\n\\n1199 \\n\\nTGAETP \\n\\nTGA ETP \\n\\n1200 \\n\\nTGALT \\n\\nTGA Lag Time \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nRespNeHepwbRUO\\n603RPTPS \\n\\nPHA \\nResponseNaHepwb\\nRUO603RPTPS \\n\\nORT21301 \\n\\nPeakHeighNaCitPl(-\\n70)LDT104PNL \\n\\nORT23761 \\n\\nPeakHeighNaCitPl(-\\n70)LDT104PNL \\n\\nORT23762 \\n\\nLagTime,NaCitPl(-\\n70)LDT-104PNL \\n\\nORT23763 \\n\\nPage 33 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\n1201 \\n\\nTGATP \\n\\nTGA time to peak \\n\\n1202 \\n\\nTGAPHOOS  TGA Peak Height, \\n\\nOOS \\n\\n1203 \\n\\nTGAEOOS \\n\\nTGA ETP, OOS \\n\\n1204 \\n\\nTGALTOOS  TGA Lag Time, OOS \\n\\n1205 \\n\\nTGATPOOS  TGA time to peak, \\n\\nOOS \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nTime,NaCitPl(-\\n70)LDT-104-PNL \\n\\nORT23764 \\n\\nPeakHtOOSNaCitPl(-\\n70)LDT104PNL \\n\\nORT23765 \\n\\nETP,OOS,NaCitPl(-\\n70)LDT104PNL \\n\\nORT23766 \\n\\nLgTimeOOSNaCitPl(-\\n70)LDT104PNL \\n\\nORT23767 \\n\\nTime,OOS,NaCitPl(-\\n70)LDT104PNL \\n\\nORT23768 \\n\\nHematology  ABO Typing \\n\\n1191 \\n\\nRHTYPE \\n\\nRh typing \\n\\nEDTAwb-315-PNL \\n\\nODT25503 \\n\\nHematology  ABO Typing \\n\\n1192 \\n\\nABOGRP \\n\\nABO Group \\n\\nEDTAwb-315-PNL \\n\\nODT25504 \\n\\nOther Tests \\n\\n \\n\\n1211 \\n\\nF8INEBU \\n\\nFactor VIII Inhibitor \\nExpedited Backup \\n\\nFVIIINjBBU(-\\n70)EXPLDT104PS \\n\\nORT19206 \\n\\n \\n\\n \\n\\nOther Tests \\n\\n \\n\\n1212 \\n\\nF8INECO \\n\\nFactor VIII Inhibitor \\nExpedited Comment \\n\\nFVIIINjBCommBU(-\\n70)EXPLDT104PS \\n\\nORT19207 \\n\\n \\n\\nOther Tests  AAV5 Antibody \\nScreening - Pre \\n\\n811 \\n\\nAAV5ABSA  AAV5 Antibody \\n\\nScreening (ARUP) \\n\\nAAV5ScrPrNaCitpl(-\\n70)IUO315RPT \\n\\nORT17830 \\n\\nImmunogeni\\n\\ncity \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\n818 \\n\\nA1AT \\n\\nAlpha-1-Antitrypsin \\n(AAT) \\n\\nAlpha1AT,NaCitPl(-\\n80)RUO387RPT \\n\\nImmunogeni\\n\\ncity \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\n819 \\n\\nA2MACROG  Alpha-2-\\n\\nMacroglobulin \\n(A2Macro) \\n\\nA2Macrog,NaCitPl(-\\n80)RUO387RPT \\n\\nORT25291 \\n\\nORT25313 \\n\\nORT21754 \\n\\nORT25292 \\n\\nORT25314 \\n\\nORT21755 \\n\\nPage 34 of 43 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nImmunogeni\\n\\ncity \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n820 \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\nB2MICROG  Beta-2-Microglobulin \\n\\n(LBTEST) \\n\\n(B2M) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nB2Microg,NaCitPl(-\\n80)RUO387RPT \\n\\nORT25293 \\n\\nORT25315 \\n\\nORT21756 \\n\\nORT25294 \\n\\nORT25316 \\n\\nORT21757 \\n\\nORT25295 \\n\\nORT25317 \\n\\nORT21758 \\n\\nORT25296 \\n\\nORT25318 \\n\\nORT21759 \\n\\nORT25297 \\n\\nORT25319 \\n\\nORT21760 \\n\\nORT25298 \\n\\nORT25320 \\n\\nORT21761 \\n\\nORT25299 \\n\\nORT25321 \\n\\nORT21762 \\n\\nORT25300 \\n\\nORT25322 \\n\\nORT21763 \\n\\nPage 35 of 43 \\n\\nImmunogeni\\n\\ncity \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\n821 \\n\\nBDNF \\n\\nBrain-Derived \\nNeurotrophic Factor \\n(BDNF) \\n\\nBDNF,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n447 \\n\\nC3 \\n\\nComplement C3 \\n\\nCYTOKINE \\nREPORTING A \\n\\nOther Tests  MAP \\n\\n418 \\n\\nCRP \\n\\nC-reactive Protein \\n\\nComplem3,NaCitPl(-\\n80)RUO387RPT \\n\\nC-ReaPtn,NaCitPl(-\\n80)RUO387RPT \\n\\nCYTOKINE \\nREPORTING A \\n\\nImmunogeni\\n\\ncity \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\nImmunogeni\\n\\ncity \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\n822 \\n\\nEOTAXIN1  Eotaxin-1 \\n\\nEotaxi-1,NaCitPl(-\\n80)RUO387RPT \\n\\n865 \\n\\nFACTVII \\n\\nFactor VII \\n\\nFactrVII,NaCitPl(-\\n80)RUO387RPT \\n\\nChemistry  MAP \\n\\n136 \\n\\nFERRITIN \\n\\nFerritin \\n\\nCYTOKINE \\nREPORTING A \\n\\nOther Tests  MAP \\n\\n554 \\n\\nFIBRINO \\n\\nFibrinogen \\n\\nCYTOKINE \\nREPORTING A \\n\\nFerritin,NaCitPl(-\\n80)RUO387RPT \\n\\nFibringn,NaCitPl(-\\n80)RUO387RPT \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n\\x0cLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\n823 \\n\\nGM_CSF \\n\\nMAP \\nCYTOKINE \\nREPORTING A \\n\\nGranulocyte-\\nMacrophage Colony-\\nStimulating Factor \\n(GM-CSF) \\n\\nGM-CSF,NaCitPl(-\\n80)RUO387RPT \\n\\nORT25301 \\n\\nORT25323 \\n\\nORT21764 \\n\\nORT25302 \\n\\nORT25324 \\n\\nORT21765 \\n\\nORT25303 \\n\\nORT25325 \\n\\nORT21766 \\n\\nORT25304 \\n\\nORT25326 \\n\\nORT21767 \\n\\nORT25305 \\n\\nORT25327 \\n\\nORT21768 \\n\\nORT25306 \\n\\nORT25328 \\n\\nORT21769 \\n\\nORT25307 \\n\\nORT25329 \\n\\nORT21770 \\n\\nORT25308 \\n\\nORT25330 \\n\\nORT21771 \\n\\nPage 36 of 43 \\n\\nLab Category \\n\\n(LBCAT) \\n\\nImmunogeni\\n\\ncity \\n\\nOther Tests  MAP \\n\\n553 \\n\\nHAPTOG \\n\\nHaptoglobin \\n\\nCYTOKINE \\nREPORTING A \\n\\nHaptoglb,NaCitPl(-\\n80)RUO387RPT \\n\\nImmunogeni\\n\\ncity \\n\\nMAP \\nCYTOKINE \\nREPORTING B \\n\\n824 \\n\\nICAM1 \\n\\nIntercellular \\nAdhesion Molecule 1 \\n(ICAM-1) \\n\\nICAM-1,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n668 \\n\\nIFNG \\n\\nInterferon Gamma \\n\\nCYTOKINE \\nREPORTING B \\n\\nIFN-gama,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n825 \\n\\nIL1A \\n\\nCYTOKINE \\nREPORTING B \\n\\nInterleukin-1 alpha \\n(IL-1 alpha) \\n\\nIL-1Alph,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n420 \\n\\nIL1B \\n\\nInterleukin-1 beta \\n\\nCYTOKINE \\nREPORTING B \\n\\nIL-1Beta,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n826 \\n\\nIL1RA \\n\\nCYTOKINE \\nREPORTING B \\n\\nInterleukin-1 \\nreceptor antagonist \\n(IL-1ra) \\n\\nIL-1ra,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n449 \\n\\nIL10 \\n\\nInterleukin-10 \\n\\nCYTOKINE \\nREPORTING B \\n\\nIL-10,NaCitPl(-\\n80)RUO387RPT \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nOther Tests  MAP \\n\\n827 \\n\\nIL12P40 \\n\\nCYTOKINE \\nREPORTING B \\n\\nOther Tests  MAP \\n\\n828 \\n\\nIL12P70 \\n\\nCYTOKINE \\nREPORTING B \\n\\nInterleukin-12 \\nSubunit p40 (IL-\\n12p40) \\n\\nInterleukin-12 \\nSubunit p70 (IL-\\n12p70) \\n\\nIL-12p40,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-12p70,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n829 \\n\\nIL15 \\n\\nInterleukin-15 (IL-15) \\n\\nCYTOKINE \\nREPORTING B \\n\\nOther Tests  MAP \\n\\n830 \\n\\nIL17 \\n\\nInterleukin-17 (IL-17) \\n\\nCYTOKINE \\nREPORTING B \\n\\nOther Tests  MAP \\n\\n831 \\n\\nIL18 \\n\\nInterleukin-18 (IL-18) \\n\\nCYTOKINE \\nREPORTING B \\n\\nOther Tests  MAP \\n\\n832 \\n\\nIL2 \\n\\nInterleukin-2 (IL-2) \\n\\nCYTOKINE \\nREPORTING B \\n\\nOther Tests  MAP \\n\\n833 \\n\\nIL23 \\n\\nInterleukin-23 (IL-23) \\n\\nCYTOKINE \\nREPORTING C \\n\\nOther Tests  MAP \\n\\n834 \\n\\nIL3 \\n\\nInterleukin-3 (IL-3) \\n\\nCYTOKINE \\nREPORTING C \\n\\nIL-15,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-17,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-18,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-2,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-23,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-3,NaCitPl(-\\n80)RUO387RPT \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nORT25309 \\n\\nORT25331 \\n\\nORT21772 \\n\\nORT25310 \\n\\nORT25332 \\n\\nORT21773 \\n\\nORT25311 \\n\\nORT25333 \\n\\nORT21774 \\n\\nORT25312 \\n\\nORT25334 \\n\\nORT21775 \\n\\nORT25267 \\n\\nORT25243 \\n\\nORT21776 \\n\\nORT25268 \\n\\nORT25244 \\n\\nORT21777 \\n\\nORT25269 \\n\\nORT25245 \\n\\nORT21778 \\n\\nORT25270 \\n\\nORT25246 \\n\\nORT21779 \\n\\nPage 37 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nOther Tests  MAP \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\n835 \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nIL4 \\n\\nInterleukin-4 (IL-4) \\n\\nCYTOKINE \\nREPORTING C \\n\\nOther Tests  MAP \\n\\n836 \\n\\nIL5 \\n\\nInterleukin-5 (IL-5) \\n\\nCYTOKINE \\nREPORTING C \\n\\nOther Tests  MAP \\n\\n448 \\n\\nIL6 \\n\\nInterleukin-6 \\n\\nCYTOKINE \\nREPORTING C \\n\\nOther Tests  MAP \\n\\n837 \\n\\nIL7 \\n\\nInterleukin-7 (IL-7) \\n\\nCYTOKINE \\nREPORTING C \\n\\nOther Tests  MAP \\n\\n838 \\n\\nIL8 \\n\\nInterleukin-8 (IL-8) \\n\\nCYTOKINE \\nREPORTING C \\n\\nIL-4,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-5,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-6,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-7,NaCitPl(-\\n80)RUO387RPT \\n\\nIL-8,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n839 \\n\\nCYTOKINE \\nREPORTING C \\n\\nMIP1A  Macrophage \\nInflammatory \\nProtein-1 alpha (MIP-\\n1 alpha) \\n\\nMIP-1Alp,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n840 \\n\\nCYTOKINE \\nREPORTING C \\n\\nMIP1B  Macrophage \\nInflammatory \\nProtein-1 beta (MIP-1 \\nbeta) \\n\\nMIP-1Bet,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n841 \\n\\nMMP3  Matrix \\n\\nCYTOKINE \\nREPORTING C \\n\\nMetalloproteinase-3 \\n(MMP-3) \\n\\nMMP-3,NaCitPl(-\\n80)RUO387RPT \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nORT25271 \\n\\nORT25247 \\n\\nORT21780 \\n\\nORT25272 \\n\\nORT25248 \\n\\nORT21781 \\n\\nORT25273 \\n\\nORT25249 \\n\\nORT21782 \\n\\nORT25274 \\n\\nORT25250 \\n\\nORT21783 \\n\\nORT25275 \\n\\nORT25251 \\n\\nORT21784 \\n\\nORT25276 \\n\\nORT25252 \\n\\nORT21785 \\n\\nORT25277 \\n\\nORT25253 \\n\\nORT21786 \\n\\nORT25278 \\n\\nORT25254 \\n\\nORT21787 \\n\\nPage 38 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nOther Tests  MAP \\n\\n842 \\n\\nMMP9  Matrix \\n\\nCYTOKINE \\nREPORTING C \\n\\nMetalloproteinase-9 \\n(MMP-9) \\n\\nOther Tests  MAP \\n\\n666 \\n\\nMCP1 \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n843 \\n\\nSCF \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nMonocyte \\nChemotactic Protein \\n1 Measurement \\n\\nMCP-1,NaCitPl(-\\n80)RUO387RPT \\n\\nStem Cell Factor \\n(SCF) \\n\\nSCF,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n844 \\n\\nTCRANTES  T-Cell-Specific \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nProtein RANTES \\n(RANTES) \\n\\nRANTES,NaCitPl(-\\n80)RUO387RPT \\n\\nOther Tests  MAP \\n\\n452 \\n\\nTIMP1 \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n419 \\n\\nTNFA \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n845 \\n\\nTNFB \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n846 \\n\\nTNFR2 \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nTIMP \\nmetallopeptidase \\ninhibitor 1 \\n\\nTIMP-1,NaCitPl(-\\n80)RUO387RPT \\n\\nTumor Necrosis \\nFactor alpha \\n\\nTNF-Alpa,NaCitPl(-\\n80)RUO387RPT \\n\\nTumor Necrosis \\nFactor beta (TNF-\\nbeta) \\n\\nTNF-Beta,NaCitPl(-\\n80)RUO387RPT \\n\\nTumor necrosis \\nfactor receptor 2 \\n(TNFR2) \\n\\nTNFR2,NaCitPl(-\\n80)RUO387RPT \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nMMP-9,NaCitPl(-\\n80)RUO387RPT \\n\\nORT25279 \\n\\nORT25255 \\n\\nORT21788 \\n\\nORT25280 \\n\\nORT25256 \\n\\nORT21789 \\n\\nORT25281 \\n\\nORT25257 \\n\\nORT21790 \\n\\nORT25282 \\n\\nORT25258 \\n\\nORT21791 \\n\\nORT25283 \\n\\nORT25259 \\n\\nORT21792 \\n\\nORT25284 \\n\\nORT25260 \\n\\nORT21793 \\n\\nORT25285 \\n\\nORT25261 \\n\\nORT21794 \\n\\nORT25286 \\n\\nORT25262 \\n\\nORT21795 \\n\\nPage 39 of 43 \\n\\n\\x0cLab Category \\n\\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test \\n\\nLab Test Name \\n\\nShort Name \\n(LBTESTCD) \\n\\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance \\nTest Code \\n\\nOther Tests  MAP \\n\\n847 \\n\\nVCAM1 \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n848 \\n\\nVEGF \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n849 \\n\\nVDBP \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\nOther Tests  MAP \\n\\n745 \\n\\nVWF \\n\\nCYTOKINE \\nREPORTING \\nD \\n\\n \\n\\nVascular Cell \\nAdhesion Molecule-1 \\n(VCAM-1) \\n\\nVCAM-1,NaCitPl(-\\n80)RUO387RPT \\n\\nVascular Endothelial \\nGrowth Factor \\n(VEGF) \\n\\nVEGF,NaCitPl(-\\n80)RUO387RPT \\n\\nORT25287 \\n\\nORT25263 \\n\\nORT21796 \\n\\nORT25288 \\n\\nORT25264 \\n\\nORT21797 \\n\\nVitamin D-Binding \\nProtein (VDBP) \\n\\nVDBP,NaCitPl \\n\\nORT25289 \\n\\n(-80)RUO387RPT \\n\\nORT25265 \\n\\nVon Willebrand \\nFactor \\n\\nvWF,NaCitPl(-\\n80)RUO387RPT \\n\\nORT21798 \\n\\nORT25290 \\n\\nORT25266 \\n\\nORT21799 \\n\\nAPPENDIX 2.1 – Laboratory Test Identifiers, Short and Long Names for blinded file \\n\\nLab Test Name \\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance Test \\nCode \\n\\nFVIII AOSCNaCitpl \\n\\nORT17362 \\n\\nFactor VIII \\nActivity One \\nStage  \\n\\nFactor VIII \\nActivity \\nChromogenic \\n\\n(-70)LDT104QT \\n\\nFVIIIAcChrNaCitpl(-\\n70)LDT104QT \\n\\nLab Category \\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test Short \\n\\nName \\n\\n(LBTESTCD) \\n\\nOther Tests \\n\\nCoagulati\\n\\n623 \\n\\nFCVIIIAS \\n\\non \\n\\n \\n\\nOther Tests \\n\\nCoagulati\\n\\n625 \\n\\nFCVIIIAC \\n\\non  \\n\\n \\n\\n \\n\\nOther Tests \\n\\nOther Tests \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n898 \\n\\nF8ASE \\n\\nFVIII Activity OSC \\nExpedited \\n\\nFVIIIAOSCNaCitpl(-70) \\nEXPLDT104 \\n\\n \\nFVIIIAOSC,SI(-70) \\nEXPLDT104 \\n\\n \\n\\n \\n\\n899 \\n\\nF8ASEBU \\n\\nFVIII Activity OSC \\nExpedited Backup \\n\\nFVIIIAOSCBU(-70) \\nEXPLDT104 \\n\\n \\nFVIIIAOSC,SI BU(-70) \\nEXPLDT104 \\n\\n \\n\\n \\n\\nORT17363 \\n\\nORT19229 \\n(AMT37448), \\nORT19209 \\n(AMT37447) \\n\\nORT19208 \\n(AMT37446), \\nORT19210 \\n(AMT37445) \\n\\nPage 40 of 43 \\n\\n\\x0cLab Category \\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test Short \\n\\nName \\n\\n(LBTESTCD) \\n\\nLab Test Name \\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance Test \\nCode \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\nOther Tests \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n \\n\\n913 \\n\\nF8ASEBUC \\n\\n \\n\\n900 \\n\\nF8ACE \\n\\nFVIII Activity OSC \\nExpedited \\nComment \\n\\nFVIII Activity \\nChromogenic \\nExpedited \\n\\n912 \\n\\nF8ACEBU \\n\\nFVIII Activity \\nChromogenic \\nExpedited Backup \\n\\n914 \\n\\nF8ACEBUC \\n\\n \\n\\n \\n\\nFVIII Activity \\nChromogenic \\nExpedited \\nComment \\n\\n \\n\\n \\n\\n \\n\\n \\n \\n\\n \\n\\n \\n\\n \\n \\n\\n \\n\\n \\n\\n \\n\\nFVIIIAOSC,Commen(-70) \\nEXPLDT104 \\n\\nFVIIIAcCh,SI(-70) \\nEXPLDT104 \\n\\nFVIIIAcChNaCitpl(-70) \\nEXPLDT104 \\n\\nFVIIIAcChBU(-70) \\nEXPLDT104 \\n\\nFVIIIAcCh,SI BU(-70) \\nEXPLDT104 \\n\\nFVIIIAcCh,Commen(-70) \\nEXPLDT104 \\n\\nORT19211 \\n\\nORT19213 \\n(AMT37443),   \\nORT19230 \\n(AMT37444) \\n\\nORT19212 \\n(AMT37442), \\nORT19214 \\n(AMT37441) \\n\\nORT19215 \\n\\n901 \\n\\nF8BDELM \\n\\nB‐domain Deleted \\nFactor VIII \\n\\nBDelF8 BU,NaCitpl(-\\n70)LDT104PS \\n\\n902 \\n\\nF8BDEL \\n\\nB-deleted FVIII \\nOut of Stability  \\n\\nBDelF8Pri,NaCitpl(-\\n70)LDT104PS \\n\\n1209 \\n\\nF8BDD_RA \\n\\n \\n\\nB-domain Deleted \\nFactor VIII \\nReanalysis \\n\\nBDDFVIIIAg NaCtpl(-\\n70)LDT104PS \\n\\n1302 \\n\\nF8BOS_RA \\n\\n1210 \\n\\nF8ACISR \\n\\n \\n\\nB-deleted FVIII \\nOut of Stability \\nReanalysis \\n\\nFactor VIII \\nActivity \\nChromogenic ISR \\n\\n864 \\n\\nF8ASISR \\n\\n \\n\\n  \\n\\nFactor VIII \\nActivity One \\nStage ISR \\n\\nBDDF8AgOOS NaCtpl(-\\n70)LDT104PS \\n\\nFVIIIACSCNaCitpl(-\\n70)LDT104PS, \\nFVIIIACSSINaCitpl(-\\n70)LDT104PS \\n\\nFVIIIAOSCNaCitpl(-\\n70)LDT104PS, \\nFVIIIAOSSINaCitpl(-\\n70)LDT104PS \\n\\nORT19687 \\n \\nORT19688 \\n \\nORT19900 \\nORT19899 \\n\\nORT263961 \\n\\nORT26087 \\n\\nORT26090 \\n\\nORT23962 \\n(AMT37442), \\nORT23963 \\n(AMT37441) \\n\\nORT23965 \\n(AMT37446), \\n\\nPage 41 of 43 \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\n\\x0cLab Category \\n(LBCAT) \\n\\nLab Sub \\nCategory \\n(LBSCAT) \\n\\nLab Test \\nIdentifier \\n(LBSPID) \\n\\nLab Test Short \\n\\nName \\n\\n(LBTESTCD) \\n\\nLab Test Name \\n(LBTEST) \\n\\nProtocol/ Covance- \\nSpecified Lab test \\n\\nCovance Test \\nCode \\n\\n \\n\\nORT23966 \\n(AMT37445) \\n\\n \\n\\nAPPENDIX 3 – Laboratory Names \\n \\nThe following entries will be used for ‘LBNAM’ (Laboratory name) \\n \\n \\n\\nLAB NAME \\n\\nCovance Central Lab  \\n\\nColorado Coag \\n\\nEurofins \\n\\nCovance Harrogate \\n\\nPrecision for Medicine \\n\\nARUP \\n\\nGenosafe \\n\\nLabCorp Burlington \\n\\nSingapore General Hospital \\n\\nBloodworks Northwest \\n\\nEsoterix \\n\\nTBD \\n\\n \\n\\nLBNAM \\n\\nCovance \\n\\nColorado Coag \\n\\n Eurofins \\n\\nCL Harrogate   \\n\\nPrecision  \\n\\nARUP  \\n\\nGenosafe  \\nLabCorp B  \\n\\nSGH  \\n\\nBloodWorks  \\n\\nEsoterix \\n\\n  \\n\\nAPPENDIX 4 – Planned Time points \\n\\n \\n\\nThe following entries will be used for 'LBTPT' (Planned time point) \\n\\nPlanned Timepoints (LBTPT) \\n\\n1 Week \\n\\n \\n\\n8-24 Hours \\n\\n \\n\\n \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 42 of 43 \\n\\n\\x0c \\n\\nAppendix 5 - Signature Page \\n\\n \\n\\nI have reviewed and approve this Data Transfer Specifications document. \\n\\n \\n\\n \\n\\n \\n  Clinical Data Manager \\n\\n____ /_____ /______  \\n dd      MON    yyyy  \\n\\nJason Delosh \\n(Printed Name) \\n\\n \\n\\n \\n\\n  Clinical Programmer \\n\\n \\n____ /_____ /______ \\n dd      MON    yyyy  \\n\\nChunzi Zhang \\n\\n(Printed Name) \\n\\n \\n\\n \\n\\n  External Vendor \\n\\n \\n____ /_____ /______ \\n dd      MON    yyyy  \\n\\nJessica Bridges \\n \\n(Printed Name) \\n\\n \\n\\n \\n\\n \\n\\nProtocol Number: 270-301 \\nVersion Number: v17.0 11DEC2020 \\n\\nPage 43 of 43 \\n\\n11-Dec-2020 | 1:29 PM PST11-Dec-2020 | 12:37 PM PST12-Dec-2020 | 5:15 PM PST\\x0c\""
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
